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 I. Introduction
The Great Lakes ecosystem continues to feel pressure from man's
activities. Perturbations caused by population growth and increased
industrialization have been shown to cause adverse effects on various sections
of the ecosystem and the potential exists for adverse human health effects
from microbial contamination of water and chemical pollutants in water and
fish.
Clearly, the potential health impacts of pollution within the Great Lakes
is of great concern to all residents within the basin. The public is well
aware that several hundred synthetic organic chemicals have been identified in
the Great Lakes Basin Ecosystem and it has expressed some fear that drinking
water supplies in the basin pose a significant health hazard. In an effort to
asce
rtai
n w
heth
er s
uch
fear
s ar
e ba
sed
on f
act,
the
Comm
itte
e re
view
ed t
he
information available on Great Lakes drinking water quality and the potential
for adverse health effects. This report discusses various aspects of Great
Lakes water quality, including the role of newly developed, short—term,
muta
geni
city
test
s in
the
asse
ssme
nt o
f th
e po
tent
ial
impa
ct o
f dr
inki
ng w
ater
on man's health and the threat to human health from microbial contamination of
drin
king
wate
r an
d re
crea
tion
al
wate
rs.
Also
disc
usse
d ar
e th
e me
rits
of
adopting watershed protection policies in safeguarding public health. The
Comm
itte
e al
so p
rovi
des
in t
his
repo
rt a
n ev
alua
tion
of n
ewly
-dev
elop
ed
techniques to measure the potential of chemicals to affect the mammalian
immu
ne s
yste
m.
Such
proc
edur
es m
ay p
lay
a si
gnif
ican
t ro
le
in f
utur
e
toxicological research on chemicals identified within the basin.
Duri
ng l
982
the
Comm
itte
e sp
onso
red
a Ro
undt
able
on t
he S
urve
illa
nce
and
Monitoring Requirements for Assessing Human Health Hazards Posed by
Con
tam
ina
nts
in
the
Gre
at
Lak
es
Bas
in
Eco
sys
tem
.
The
Pro
cee
din
gs
of
the
Roun
dtab
le w
ere
prep
ared
by t
he p
arti
cipa
nts.
A su
mmar
y of
the
majo
r po
ints
of
thi
s r
epo
rt
is
pro
vid
ed
by
the
Com
mit
tee
wit
h t
he
int
ent
tha
t t
hos
e w
ho
are
initiating or reviewing programs designed to assess man's exposure to
env
iro
nme
nta
l c
ont
ami
nan
ts
will
be
able
to
pro
vid
e d
ata
tha
t a
re
mor
e
appropriate for future health hazard assessments.
Fin
all
y,
the
Com
mit
tee
has
pro
vid
ed
add
iti
ona
l c
lar
ifi
cat
ion
of
its
haz
ard
asse
ssme
nt o
f Gr
eat
Lake
s c
hemi
cals
.
In t
he l
98l
repo
rt o
f th
e Co
mmit
tee,
che
mic
als
ide
nti
fie
d w
ith
in
the
Gre
at
Lak
es
Bas
in
Eco
sys
tem
as
of
l97
8 w
ere
classified according to their potential impact on human health. Several
asp
ect
s w
ere
con
sid
ere
d b
y t
he
Com
mit
tee
,
inc
lud
ing
new
ly-
fou
nd
dat
a o
n
toxi
city
and
expo
sure
whic
h ha
ve b
een
eval
uate
d an
d th
e Ta
bles
from
last
yea
r's
rep
ort
mod
ifi
ed
acc
ord
ing
ly.
The
se
upd
ate
d T
abl
es
sho
uld
be
of
gre
ate
r
utility to managers of toxic chemical programs within the basin.
The
rec
omm
end
ati
ons
of
the
Com
mit
tee
are
rep
rod
uce
d
in
Cha
pte
r 8
.

 2.
Drinking
Water
and
Public
Health
2.1 INTRODUCTION
Until the last few years, residents in the Great Lakes Basin had assumed
that their abundant fresh water resources were safe from the adverse effects
of population growth and increased industrialization. Population growth and
industrialization can result in pollution of drinking water sources. As the
quality of the source water and/or drinking water deteriorates, the potential
for the occurrence of disease and infection due to pathogenic organisms such
as bacteria, viruses, protozoans and helminths and the toxic effects of
chemicals, increases.
The public has, over the last few years, become better informed regarding
the numbers of chemicals identified in drinking water and has continually
voiced concern over the fact that many identified chemicals cause chronic
adverse biological effects in mammalian species. Hence the potential
long—term health effects of the chemicals found in drinking water are of
concern.
The Health Effects Committee addressed the subject of drinking water and
human health in an attempt to delineate the extent of any health risk from
present drinking water quality, both chemical and microbiological.
2.2 CHEMICAL CONTAMINANTS FOUND IN DRINKING WATER FROM THE GREAT LAKES
 
All drinking water produced from sources within the Great Lakes Basin
normally contains a complex mixture of chemicals. These chemicals and
elements are of natural origin or a direct result of man's activity.
Many of the inorganic elements are of negligible toxicity and are in fact
essential to man (e.g. calcium, zinc and magnesium). Others are recognized
toxicants (e.g. lead, cadmium and arsenic). In addition to the inorganic
elements found in drinking water, particulate matter including asbestos has
also been detected.
Many organic chemicals have been identified, some of natural origin (e.g.
humates), while others arise solely from man's activities (industrial and
municipal waste discharges, hazardous waste disposal and water treatment
processes). There is a wider diversity of organic than inorganic compounds
found in drinking water. In fact, a large proportion of the organic fraction
of drinking water has yet to be identified. Also, many of the organic
chemicals have unknown toxicity.
In general, the inorganic elements have been monitored for decades and
health related standards set fer the major toxic elements. No adverse health
effects have been reported as a result of toxic inorganic elements in drinking
water within the Great Lakes Basin. Most recent public concern has focused on
the many organic chemicals found in drinking water.
Worldwide, over 700 organic chemicals have been identified in man's
drinking water. Many of these chemicals have been identified in samples of
drinking water from the Great Lakes. Drinking water guidelines and/or
standards have been set for only a few of the identified organic chemicals.
 
   
   
Ho
we
ve
r,
su
rv
ei
ll
an
ce
st
ud
ie
s
wi
th
in
the
Gr
ea
t
La
ke
s
Ba
si
n
in
di
ca
te
th
at
org
ani
c c
hem
ica
ls
in
dri
nki
ng
wat
er
are
pre
sen
t a
t t
he
low
par
ts-
per
-bi
lli
on
le
ve
l
or
le
ss
.
Th
e
ne
ed
fo
r
dr
in
ki
ng
wa
te
r
gu
id
el
in
es
or
st
an
da
rd
s
fo
r
new
ly-
ide
nti
fie
d
che
mic
als
may
be
asc
ert
ain
ed
by
suc
h f
act
ors
as:
)
am
bi
en
t
le
ve
ls
in
ra
w
an
d
fi
ni
sh
ed
wa
te
r;
) industrial production and use data;
)
ph
ys
ic
al
an
d
ch
em
ic
al
pr
op
er
ti
es
;
an
d
) evidence of toxicity in animals or man.
Su
rv
ei
ll
an
ce
for
pr
es
en
tl
y
un
id
en
ti
fi
ed
or
ga
ni
cs
mu
st
be
en
co
ur
ag
ed
in
add
iti
on
to
the
con
tin
uat
ion
of
com
pli
anc
e m
oni
tor
ing
.
Gui
del
ine
s
for
.
su
rv
ei
ll
an
ce
and
mo
ni
to
ri
ng
of
dr
in
ki
ng
wa
te
r
and
dr
in
ki
ng
wa
te
r
su
pp
li
es
ar
e
ref
err
ed
to
in
the
Pro
cee
din
gs
of
the
Rou
ndt
abl
e o
n t
he
Sur
vei
lla
nce
and
Mo
ni
to
ri
ng
Re
qu
ir
em
en
ts
fo
r
As
se
ss
in
g
Hu
ma
n
He
al
th
Ha
za
rd
s
Po
se
d
by
Contaminants in the Great Lakes Basin Ecosystem (l).
2.3 DRINKING WATER CONCERNS-MICROBIOLOGICAL
The
pri
nci
pal
obj
ect
ive
of
dri
nki
ng
wat
er
tre
atm
ent
is
the
eli
min
ati
on
of
mac
ro-
and
mic
ro-
org
ani
sms
cap
abl
e
of
cau
sin
g w
ate
rbo
rne
dis
eas
e.
Suc
h
org
ani
sms
may
be
fou
nd
in
sur
fac
e
and
gro
und
wat
ers
at
all
tim
es,
in
num
ber
s
dep
end
ent
upo
n
the
deg
ree
of
con
tam
ina
tio
n.
Maj
or
out
bre
aks
are
pre
ven
ted
by
eff
ect
ive
dis
inf
ect
ion
pro
ced
ure
s.
The
ina
cti
vat
ion
of
wat
erb
orn
e d
ise
ase
or
ga
ni
sm
s
re
ma
in
s
of
pa
ra
mo
un
t
im
po
rt
an
ce
for
th
e
pr
ot
ec
ti
on
of
pu
bl
ic
he
al
th
.
A n
umb
er
of
syn
the
tic
org
ani
c
che
mic
als
has
bee
n
fou
nd
in
wat
er
sup
pli
es.
So
me
are
pr
es
en
t
in
th
e
so
ur
ce
wa
te
rs
, o
th
er
s
are
pr
od
uc
ed
as
a
re
su
lt
of
dis
inf
ect
ion
or
oth
er
tre
atm
ent
pro
ces
ses
.
The
re
is
a l
ack
of
def
ini
tiv
e
ev
id
en
ce
th
at
th
es
e
su
bs
ta
nc
es
,
in
the
co
nc
en
tr
at
io
ns
fo
un
d
in
mo
st
wa
te
rs
,
are
har
mfu
l
alt
hou
gh
pru
den
ce
wou
ld
dic
tat
e t
hat
lev
els
be
kep
t a
s l
ow
as
pos
sib
le.
The
lev
els
of
the
se
con
tam
ina
nts
can
be
red
uce
d
by
the
use
of
car
bon
fil
ter
s o
r b
y a
lte
rat
ion
of
the
typ
e o
f d
isi
nfe
cti
ng
age
nt
or
its
poi
nt
of
app
lic
ati
on.
Whi
lst
suc
h
mod
ifi
cat
ion
s
may
rem
ove
the
con
tam
ina
nts
,
or
red
uce
the
amo
unt
s p
rod
uce
d,
the
y m
ay
als
o c
omp
rom
ise
the
mic
rob
iol
ogi
cal
saf
ety
of
the
pro
duc
e w
ate
r,
eve
n t
o t
he
poi
nt
of
cre
ati
ng
a s
eri
ous
hea
lth
hazard.
The
dan
ger
lies
in
the
pot
ent
ial
for
mul
tip
lic
ati
on
on
the
car
bon
fil
ter
s
of
a g
rea
t v
ari
ety
of
mic
roo
rga
nis
ms
whi
ch
occ
ur
in
nat
ura
l
wat
ers
.
In
add
iti
on,
so-
cal
led
aft
erg
row
th
of
the
se
bac
ter
ia
in
the
dis
tri
but
ion
sys
tem
may
occ
ur
if
car
bon
fil
ter
s
or
oth
er
mea
sur
es
cit
ed
abo
ve
hav
e
res
ult
ed
in
a
dec
rea
se
or
eli
min
ati
on
of
res
idu
al
dis
inf
ect
ant
.
The
typ
es
of
bac
ter
ia
inv
olv
ed
in
suc
h g
row
ths
inc
lud
e s
eve
ral
opp
ort
uni
sti
c p
ath
oge
ns
(al
so
ref
err
ed
to
as
sec
ond
ary
inv
ade
rs)
whi
ch
are
har
mle
ss
to
mos
t h
uma
ns,
par
tic
ula
rly
whe
n
pre
sen
t
in
sma
ll
num
ber
s,
but
whi
ch
can
be
ver
y
dan
ger
ous
to
'
ind
ivi
dua
ls
wit
h l
owe
red
res
ist
anc
e a
nd
gen
era
lly
to
the
age
d a
nd
the
ver
y
you
ng.
The
red
uct
ion
of
res
idu
al
dis
inf
ect
ant
lev
els
aff
ect
s
the
eli
min
ati
on
of
pat
hog
ens
whi
ch
may
hav
e e
nte
red
a d
ist
rib
uti
on
sys
tem
thr
oug
h l
oss
of
lin
e
(l)
IJC
Hea
lth
Eff
ect
s C
omm
itt
ee,
hel
d M
arc
h
l7-
l8,
l98
2,
Mic
hig
an
Sta
te
University, East Lansing.
 pressure, cross connections, or as the result of other imperfections either in
the treatment or in the distribution system (2)(3).
A modification in water
plant treatment practice may therefore eliminate one potential public health
concern at the expense of creating the very real hazard of acute waterborne
illness. It follows that water purveyors and regulatory agencies must
carefully weigh the benefits and dangers of any process modification.
Particular caution is in order with regard to the use of "point-of-use“
water purifiers, i.e., filters which are installed on individual household
taps. These units may be purchased by consumers who are confused and
concerned by press reports and advertising material and who respond to an
exaggerated or totally unsubstantiated fear of contamination of a local water
supply.
Manufacturers do not acknowledge local and regional variations in
drinking water quality. Theconsumer usually has insufficient information on
which to base an intelligent decision on the desirability of point-of-use
treatment or the type of units suited to a particular need. Many contaminants
which may be of concern are not amenable to the treatment these units provide.
Further and most importantly, the use of these devices may create
hazardous situations in that large numbers of bacteria may be able to grow
within the units and may leach from them into the product water. Hence, the
performance of these units depends greatly on the chemical and microbiological
characteristics of the water supply. Adequate monitoring, which would assure
the effective and safe operation of these devices is rarely, if ever, provided.
If a serious chemical contamination problem exists it could be dealt with
effectively and in a timely fashion by the installation of point-of-use
filters. By this is meant that contamination has been detected and that it is
amenable to this form of treatment and that centralized treatment or an
alternate source of water cannot be provided. Public Health authorities are
in a position to determine if and where such a situation exists. If
point-of—use devices are installed, an adequate monitoring program should be
instituted to assure safe operation. In addition, a schedule for the
replacement or regeneration of the filters appropriate for the specific
situation should be instituted and adhered to by the households affected.
2.4 PREVENTIVE MEASURES: WATERSHED PROTECTION
An important element in the protection of drinking water quality is the
protection of the source, be it ground- or surface water. This principle has
been applied for many years in the prevention of waterborne infectious
disease. The vastly increased production and use of synthetic organic
chemicals has added new significance to this concept, but, unfortunately few
jurisdictions have developed the administrative tools to apply it effectively.
(2) Tobin, R.S., D.K. Smith and T.A. Lindsay (l98l). Effects of activated
carbon and bacteriostatic filters on microbiological quality of drinking
water. App. Envir. Microbiol. 41:646-65l.
(3) Environmental Health Directorate (l977). Survey and test protocols for
point-of—use water purifiers. Report No. 77-EHD-8 Health and Welfare
Canada, Ottawa.
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a s
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dis
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The Great Lakes and other surface waters are characterized by a great
potential
for
the
"assimilation"
(degradation,
inactivation)
of
waste
material.
Also,
many contaminants pass
through without
ever reaching the
drinking water
intakes.
Watershed protection for the purpose of preserving
the Great Lakes as a source of drinking water thus requires strict limitations
on
discharges
from
all
materials
which
are not
sufficiently
degraded
or
inactivated.
The
Committee,
in
its
l98l
Report
and
in
sections
of this
Report
recommend
surveillance for certain substances of concern which are either
non-biodegradable or which are biodegradable but discharged in amounts large
enough to be detected at locations for removal from the point of discharge.
The stakes are high: if Great Lakes water should become more contaminated and
unsuitable for drinking, or very expensive to treat, most urbanized areas in
the Great Lakes
Basin would have great difficulty in locating alternative,
safe sources of water.
2.5 STATUS AND CONCLUSIONS
 
The Committee is aware of large data bases on health statistics within the
basin and the results of epidemiology studies throughout the United States
which attempt to correlate drinking water quality (particularly the level of
certain organic chemicals) and human health status. Such studies are
extremely complex and should not be subjected to a cursory review by
non-epidemiologists. Although studies to date appear to neither support nor
refute positive animal cancer bioassays, the Committee will ask for expert
advice from a group of epidemiologists before reaching a final conclusion
regarding this important area of research.
Currently, the public health hazard posed by microbiological contamination
of drinking water carried out within the Great Lakes Basin is extremely low.
Given present day drinking water technology, this situation should not change,
unless arbitrary decisions are made to alter present disinfection procedures.
Adequate public health protection requires drinking water free from microbial
contamination and any attempt to lower the trace levels oforganic chemicals
in drinking water must not compromise this requirement. The efficacy of any
newly developed disinfection technique must be ascertained under field
conditions before adoption.
Present data on the levels of organic chemicals found in drinking water
supplies within the basin and the known toxicity of many of these chemicals,
do not indicate an emergency-type public health problem. However, given the
amounts of hazardous wastes stored around the Great Lakes and the increasing
demand by society for synthetic chemicals, there may well be an emerging
public health problem. Prompt remedial actions on hazardous chemical dump
sites and improved effluent controls are required.
Many investigators have attempted to use microbial mutagenicity tests to
delineate human health hazards from chemical exposures. Such a procedure is
not supported by known physiological differences between bacteria and mammals
and between the biological response to chemicals of isolated bacterial cells
and whole animals. Short-term bacterial tests are extremely valuable for
setting priorities for future studies, but the actual hazard to man of
chemical contaminants can only be determined, at this time, by experiments in
whole animals or by large-scale, well-designed epidemiological studies.
 
 2.6 RECOMMENDATIONS
Chemical
1. Surveillance of drinking water supplies for new organic contaminants must
be increased.
2. The Parties should augment presenttoxicology programs to study the
toxicity (including carcinogenicity) of chemicals identified in drinking
water supplies within the Great Lakes Basin.
3. More emphasis should be placed on the toxicological evaluation of the
non-chlorinated organic chemical fraction fron drinking water.
Microbiological
4. Modification of drinking water treatment plant operations should be
undertaken with caution and on an individual basis following adequate
studies to determine:
a) the efficacy of the modified treatment process in removing
contaminants of concern; and
b) the impact on the microbiological quality of the product water both
at the plant and, more importantly, in the distribution system;
5. Point—of—use water treatment units should be used only where conventional
approaches are not applicable and then only with an adequate monitoring
program and regeneration/replacement schedule;
6. Additional research into the relationship between particulate
matter/turbidity and waterborne illness, especially in recreational
waters, should be undertaken to determine whether improved particulate
removal during sewage and stormwater treatment should be recommended; and
7. The jurisdictions should be urged to recognize the need for the assessment
of chronic health problems from low level exposure to microbiological
contaminants.
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3.1 INTRODUCTION
In its 1981 Report, the Committee dep1ored the inadequacy of the current
scientific basis for regu1ating recreationa1 water qua1ity. Resu1ts of a
recent study (Dufour, 1982) shed new 1ight on the issue.
A brief account
fo11ows.
3.2 DISCUSSION
Regu1atory agencies decide upon the suitabi1ity for swimming of
recreationa1 waters on the basis of standardized bacterio1ogica1 tests for
indicator bacteria.
Reports on swimming-re1ated gastrointestina1 i11ness,
however, show on1y a weak correlation, if any, with indicator bacteria1
densities.
In addition and independent of indicator bacteria1 densities, an
increased risk seems to be associated with exposure to untreated municipa1
wastewater (Committee on Bathing Beach Contamination, 1959). Severa1
jurisdictions make sanitary surveys a part of their recreationa1 water
survei11ance and ban swimming near outfa11s of untreated municipa1 wastewater
or near active combined sewer overf1ows.
The infectious dose for pathogenic microorganisms varies with species.
For many sa1mone11a bacteria it is in the order of 105 - 106 bacteria
(Dud1ey, et a1., 1976) whereas for shige11a a 1ower infectious dose (102 -
103 bacteria)_has been postu1ated (Levine, gt_al,, 1973). Estimates of
pathogen density in recreationa1 waters which meet or s1ight1y exceed current
co1iform standards, suggest that a swimmer must ingest a substantia1 vo1ume of
water in order to acquire an infectious dose (Fuhs, 1975). In a11 such
ca1cu1ations it is assumed that the pathogens and the indicator bacteria occur
sing1y, not in c1umps. The prob1em is that in many instances this assumption
may not be correct. A sing1e feca1 partic1e derived from a person suffering
from gastrointestina1 i11ness conceivab1y can contain a 1arge number of
bacteria or viruses sufficient to constitute an infectious dose. In the case
of intestina1 viruses, the 1ike1ihood that they remain c1umped and associated
with ce11 debris is very great (We11ings, et_al., 1976, F1oyd and Sharp,
1977). In fact, it is entire1y possib1e that c1umps of virus partic1es are
the most important cause of swimming-re1ated gastrointestina1 i11ness. The
same may app1y to the pathogenic bacteria as we11. In the presence of such
feca1 partic1es, infections can occur even at re1ative1y 10w 1eve1s of
indicators and/or pathogens per unit vo1ume of water when tested. The
increased resistance to inactivation by ch1orine of bacteria and viruses which
are associated with or enc1osed in organic matter is an exacerbating factor
(Boardman and Sprou1, 1977; Young and Sharp, 1977).
A recent report by Dufour (1982) suggests the answer to the question of
the poor corre1ation between indicator bacteria1 densities and
swimming-re1ated disease and it is concerned with the turbidity and
particu1ate content of the water. BacteriaT counts in recreationa1 waters
were obtained after fi1tering the samp1es through 3pm membrane fi1ters. In
addition, the 3pm fi1ter was processed to show indicator bacteria associated
with partic1es retained by thefi1ter. The count of these partic1es, which
are presumab1y of feca1 origin, was more c105e1y corre1ated with subjective1y
 
  
  
 
perceived gastrointestinal symptoms than was the number of bacterial
indicators determined along conventional lines. This seems to support the
foregoing hypothesis. However, the new method is still extremely crude and
the following caveats apply.
Particulate matter may be reworked in the aquatic environment in many
different ways as follows:
0 wastewater treatment plants depending upon the type of treatment,
proouce biological floc or chemical precipitates. Both types of
particulates may have indicator bacteria adsorbed to them but do not
necessarily contain clumps of pathogenic bacteria or viruses;
0 in all surface waters, new particulates form from material in the
surface microlayer (see Fuhs, l982) and by microbial action in the
sediments. These new particles also may have indicator bacteria
attached to them in numbers possibly unrelated to the numbers of
pathogens present; and
o in estuaries, new particulate matter is formed in large quantities by
coagulation processes, unrelated to sewage contamination.
The assumed relationship between risk of infection and particulate matter
will hold less where these mechanisms come into play. There have been
observations that pathogens persist in sediment (Van Donsel and Geldreich,
l97l), but the correlation with indicator bacterial densities is poorly
understooo.
Additional research is required to yield final clarification of the
relationships between particulate matter, turbidity and illness. But in the
interim it would appear that recreational waters could be protected by
improved particulate removal at wastewater treatment plants and from combined
sewer overflows. thorination of sewage effluents has come under attack for
good reasons. With improved particulate removal, it would seem that the risk
of infection may be reduced even without chlorination and if chlorine is
applied, a relatively small dose would be sufficient to reduce the number of
unprotected bacteria or viruses. It should also be noted that particulate
removal is an important consideration in the removal of phosphates from
wastewater effluents. /
3.3 RECOMMENDATIONS
A more rational basis for our understanding of health risks from swimming
should be obtained through additional research. It appears that safe waters
for swimming can be provided without excessive reliance on the chemical
disinfection of wastewater effluents.
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4.1 INTRODUCTION
The
purpose
of this
chapter
is
to
discuss
studies
on
the mutagenicity
of
drinking water
in the bacterial
system Salmonella typhimurium.
Results
from
such mutagenicity tests have been shown to be useful
in predicting the
carcinogenic potential of chemicals.
This chapter discusses how mutagenicity
studies
in bacteria
are carried
out,
some
of the
results
obtained
and
the
proper interpretation of such data relating to mutagenic activity in drinking
water.
 
Municipal
drinking water in the United States and Canada is usually
supplied by nearby rivers or lakes which contain varying amounts of natural
and synthetic organic compounds.
Hundreds of chemicals have been detected in
drinking water and many of these are formed by reactions of the constituents
of the untreated water with chlorine during disinfection.
Certain of these
compounds (e.g. dichloromethane and chloroform) are known to be mutagenic
and/or carcinogenic in experimental organisms at doses many thousands of times
greater than the trace levels to which people are exposed through the water
supply.
Is it possible that trace levels of chemicals in drinking water can
contribute significantly to our overall burden of chemical mutagens and/or
carcinogens?
North Americans are exposed to many chemicals in varying
amounts, such as food additives, drugs and pesticides, products used in
hobbies and the household, solvents, exhaust gases, cigarette smoke and
occupational chemicals in the workplace.
In relation to these, drinking water
is a very minor contributor to our overall chemical exposure, but it is a
source of chemicals to which all who drink tap water are exposed for a
lifetime.
Therefore, it is important to enter into research programs to study
the possible toxic potential of drinking water.
One approach has been the use
of sensitive bacterial assays that are capable of detecting low levels of
mutagens (potential carcinogens) in environmental samples.
It is imperative to acknowledge that screening drinking water or extracts
of drinking water for bacterial mutagenicity is not a reliable way to
determine safety or hazard of any drinking water source.
Materials that are
mutagenic in bacteria are not always mutagenic or carcinogenic in whole
animals (and vice versa). There are many reasons for the differences,
including tissue distribution, metabolism and DNA repair. Bacterial testing
is valuable for setting priorities for further investigations, but human risk
must be determined on the basis of iﬂ_VlV0 mammalian studies.
4.2 METHODOLOGY
The most commonly used bacterial test system is the Salmonella/mammalian-
microsome assay for the detection of point mutations. Many chemicals that are
mutagenic in this assay also induce mutation and cancer in rodents. A high
correlation between Salmonella mutagenicity and carcinogenicity has been
noted, although percent correlations vary withthe types of chemicals chosen
for study. The value of this test in general is enhanced by the incorporation
of a mammalian—microsomal activating system, in the form of a rat-liver
l3
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homogenate ($9). This material contains enzymes which can convert promutagens
into genetically active mutagens, detectable by different types of reversion
mutations in different strains of Salmonella typhimurium. 0f the five
standard tester strains for Salmonella, most testing of drinking water
extracts involves only the two most sensitive, TA98 for detection of
frameshift mutations and TAlOO for base substitution mutations. Although the
extent of mutagenicity testing is limited by the milligram quantities of
extracts available, an effort must be maoe to look for dose-related increases
in mutagenic activity with some lethality at the highest dose(s).
 
The criteria used by most investigators for deciding what may be regarded
as a positive response in Salmonella, involve at least a doubling of the
spontaneous background of mutants and evidence of a dose response
(dose-related increases of mutantslf_ A result is judged to be negative when
both conditions are not fulfilled. These criteria are embodied in what is
referred to as "The Modified Two-Fold Rule", which has been found to be the
most sensitive index of true positive and negative responses compared to other
biological and/or statistical analyses.
One approach to bacterial mutagenicity testing of drinking water has been
to test unconcentrated water, just as it comes out of the tap, using the
Salmonella assay or a more sensitive fluctuation test (a liquid culture assay
with 50 replicates per dose). Such studies on unconcentrated water samples,
whatever the source, lead to variable results.
If unconcentrated samples cannot be used reliably, what approach should
then be taken? It is not practical to test all known constituents of drinking
water for possible toxic effects, nor is it practical even to identify every
contaminant that is present in trace amounts. Consequently, attempts are
underway to study the mutagenic potential of drinking water by testing
concentrates or extracts. By extraction and concentration, enough material is
obtained to produce measurable mutagenic activity even in the least
contaminated types of drinking water. With this approach, one can then make
comparisons of the level of mutagenicity in different locations and
seasonally, etc., provided that the concentration steps are sufficient to
produce detectable mutagenicity in most extracts. In addition, this procedure
permits testing of chemical doses which meet internationally accepted
protocols for the S. typhimurium assay.
One of the most widely adopted methods for selectively concentrating
certain of the non—volatile dilute organics present in drinking water is the
use of XAD macroreticular resins. The classes of organics that do not adsorb
to XAD-2 (or -4/8) do not seem to be major contributors of mutagenic
activity. XAD resins can be conveniently used in laboratory or field stuoies
if they are placed in cartridges to be connected to taps or pumps which supply
water at constant flow rates. The columns can be eluted with solvents (e.g.
acetone and hexane), with an evaporation step before testing, or elution can
be done with the test solvent itself, dimethylsulfoxide (DMSO). A problem
with both methoos is the possible interaction of the test material and
solvent, as has been shown for certain compounds and the changing properties
of extract solution stored in DMSO.
An approach to overcome some of these problems has been to split the XAD
eluent, take half to dryness (dissolved in DMSO) and reduce the volume of the
other half (by evaporation) for direct testing without DMSO. Comparisons have
l4
been
made
of
the
initial
slopes
of
the
dose-effect
curves
for
such
dry
and
liquid
extracts
from
the
same
samples.
In
certain
cases
little
or
no
difference between slopes
is observed,
which probably means an absence of
interaction
of
the
dry
extract
with
DMSO;
however,
for
other
samples,
the
initial slopes do not overlap, indicating that choice of solvent does
contribute
at
times
to
the
pattern
of
extract
mutagenicity
observed.
In
addition, extracts of water in dimethylsulfoxide show reduced mutagenicity
after
storage
for
2-3
days.
These
findings
emphasize
the
importance
of being
cognizant of possible solvent effects.
4.3. MODEL STUDIES
Using the general methods and criteria described above, many studies have
been performed on water supplies in Europe, Africa and North America.
For the
purpose of the
International
Joint Commission,
perhaps the most pertinent
investigations are those involving samples from 45 treatment plants throughout
Canada,
including l2 municipalities
using the Great Lakes as the source of
drinking water.
Since previous studies have shown that the mutagenicity of
samples varies from season to season, all plants were sampled twice during the
year (usually August/September and November/December). Positive effects were
found for at least one sample from 44 to 45 treatment plants.
Since drinking
water from the Great Lakes has been reported to contain levels of
anthropogenic compounds lower than those found in drinking water from river
sources, comparisons of mutagenic potencies were made amongst the three types
of water sampled (river, lake, well).
Average mutagenicity of the extracts
was higher in the summer samples for each of the three types of water and the
mutagenic activity found in concentrates of organics from well water was lower
compared to river or lake sources. No consistent difference in the
mutagenicity of extracts was apparent between rivers and lakes since extracts
of river sources on the average were more mutagenic in winter and less in
summer.
The same pattern was found when the Great Lakes sources were
considered separately and compared to river sources.
The mutagenic potencies of extracts from different locations varied
considerably and efforts have been made to relate mutagenicity with treatment
parameters and the presence of various chemicals.
In a Great Lakes study of
l2 municipalities, no compelling trends were apparent. In a Cross Canada
Survey, the potency and analytical data were analyzed with the help of a
computer. The highest correlations were found with non—chlorinated aromatic
compounds (e.g. ethyl benzene, toluene and xylenes). Coefficients of
correlation with trihalomethanes, chemicals that have been the subject of much
recent concern, were lower. It has been shown that a compound responsible for
much of the mutagenicity in some extracts of Cincinnati drinking water was
also non-chlorinated. Such results indicate the need for additional
toxicity/mutagenicity studies on the non-chlorinated organic compounds found
in drinking water.
Another finding of interest in these studies concerned the role of a rat
liver enzyme preparation (59) for mammalian metabolic activation in the _ .
bacterial assay. In no case did 89 enable the detection of mutagenic activ1ty
of an extract that was negative without 59. Furthermore, the presence of 59
generally reduced the mutagenic responses observed in its absence.
l5
   
  
4.4 CONCLUSIONS
Results from such studies can be interpreted to mean that drinking water
contains trace levels of compounds that, when concentrated 5 x 104-f01d, are
likely to be mutagenic in a bacterial screening test. It is often concluoed
that differing amounts of these compounds in the extracts can lead to
different levels of mutagenic response, although it must be noted that when
complex mixtures of componds are tested, many additive, synergistic and
antagonistic interactions may take place. It cannot be assumed that the same
interactions that occur in the Salmonella test will occur in other
mutagenicity assays or in the whole animal.
For the interpretation of data from bacterial mutagenicity studies, it is
important to recognize their preliminary nature. Screening and monitoring
experiments with bacteria may provide the initial warning of a potential
problem, but comprehensive evaluation of a drinking water source for its
chemical safety must include data from an appropriate battery of short-term
studies followed, when needed, by jn_vivo animal bioassays. Thus, a maJor
value of bacterial testing is to enable investigators to identify particular
water sources or types of treatment for further assessment by other methoas
for the ultimate goal of determining human risk.
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 Antigens are found on and in cells and infectious agents, or may be defined
chemical
entities.
Antibody
production
usually
requires
the
participation
of
macrophages (as accessory cells) and two types of lymphocytes, B(bursal)-cells
and
T(thynus)-cells.
The
nomenclature
of the
two
large
lymphocyte
classes
referred to above is derived from anatomic sites or equivalents through which
young
cells
pass
during maturation.
Upon
encountering
an
antigen,
macrophages
are believed to process and 'present' it to T—cells (l0) and to release a
variety
of chemicals
among which
are
stimulators
of T-cell
divisions
(reviewed
in ll).
Antigen-responsive T-cells are generated during this process and in
turn,
release
other
chemicals
known
as
lymphokines
which
enhance
or
suppress
the responses of other participating cells (l2).
In general, two subtypes of
antigen-specific
T-cells
result
from
cell
division:
T-cells
which
provide
"help" to the precursors of antibody-producing cells and T-memory cells that
revert
to
a quiescent
stage,
forming
a pool
of
antigen—specific
cells
capable
of rapid numerical
growth on re—exposure to the antigens
(l2).
B-lymphocytes
respond
to
antigen
by undergoing
differentiation
to
either
end-stage
plasma
cells which synthesize antibodies or to B—memory
cells.
Cells
of the
T-lymphocyte
lineage
are
also
the
effectors
of
cell
mediated
immune responses.
Although antibodies
are produced by cells, the distinction
drawn
by
immunologists
between
humoral
and
cellular
immunity
is
the
ability to
transfer humoral
immunity to an antigenically naive recipient with cell—free,
antibody-containing serum.
Cell
mediated
immunoreactivity
can
be
transferred
by immune T-cells.
In very recent years, the use of sophisticated techniques
has
demonstrated
numerous
subsets
of T-cells.
Classification
systems
have
attempted to describe subsets of T-cells which respond
to tumor cells,
foreign
tissue antigens
and infectious
agents.
Delayed hypersensitivity
(e.g. poison
ivy, positive tuberculosis skin test), so-called because of the time (usually
approximately 48
h)
between
antigen
contact
and
host
response,
is
also
mediated by T-cells.
This response,
while usually beneficial
to the host
(e.g. during parasitic and bacterial
infections) also is the pathologic basis
of certain diseases,
including tuberculosis
and poison
ivy.
5.3
ALTERATION
OF
THE
IMMUNE
SYSTEM
A
variety
of methods
has
been
applied
to
assess
levels
of
immunocompetence
in humans
and experimental
animals.
Some of the most widely employed assays
are briefly
described
in Table
5.1.
There
is
a variety
of advantages
and
disadvantages
in all of the assays described.
However,
the host resistance
assays
provide
the
greatest
overview
of immunocompetence
since
they
depend on
a multicompartmental
response by the entire organism rather than by cultured
cells.
In addition,
these
assays
directly
reflect
the
integrity of
the major
functions of the immune system,
i.e. controlling
infection
and neoplastic cell
proliferation.
It should
be
noted
that
while
the
tests
for
immune
competence
listed in Table 5.l have been accepted as scientifically valid
and provide an
insight
into
the
toxic
mechanism(s)
of
tested
compounds,
at
this
time
such
tests are not used
as a basis for regulatory decisions.
A
variety
of
chemical
agents
is
known
to
affect
immunocompetence.
Therapeutic manipulation of the immune system is a common tactic in combating
certain
disease
processes
that
result
in
an
immune
response
against
the
self
(e.g. in rheumatoid arthritis).
Deliberate local or systemic suppression of
the
immune
response
is
also
employed
to
control
such
diverse
responses
as
the
itching and swelling characteristic of mosquito bites and poison ivy or the
life-threatening
events
accompanying
acute
rejection
of
organ
transplants
l8
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TABLE 5.]
SELECTED ASSAYS FOR EVALUATION OF INMUNOCOMPETENCE
 
ASSAYS
TYPE.l
IMMUNE FUNCTION ASSESSED
COMMENT
Host resistance
In vivo,
"Whole Body” immunity
Tumor cells, bacteria, viruses, and parasites, are
spec1f1c
used to challenge animals and tumor development, time
of recovery from infection and/or death rate is
recorded.
 
Antibody production
In vivo,
Production of antibody to a
Antibody production is stimulated in test animals
spatiiic
specific antigen
by antigen injection and is measured in vitro
 
Delayed hypersensitivity
En vivo,
Cell mediated immunity
Evaluates a portion of the complex responses known as
response
spec1fic
cell mediated immunity
Lymphocyte proliferation
In vitro,
Proliferative capacity of
Provides a general indication of the ability of cells
non-specific
T-cells and B-cells
to divide when stimulated with powerful, non—specific
agents
 
1
9
Cell mediated
in vitro,
Destruction of tumor cells
Reflects the integrity of a “first line of defense"
cytotox1city
specific/
by natural killer cells or
against tumors (NK cells) and antigen-specific
non-specific
T—killer cells
immunity to tumors (T—killer cells)
Phagocytosis
In vitro,
Engulfment of target cells
Measures capacity of phagocytic cells to engulf
non—specific
by macrophages or
bacteria or other targets, which may or may not be
neutrophils
pre-coated with antibody (see text)
1Specificity
indicates
responses
to
a particular antigen;
non—specific
responses
are generally
directed against
a group
characteristic rather than an individual
characteristic such as an antigen.
 
 (reviewed in l3). Numerous agents are capable of inducing immunosuppression
by a variety of direct and indirect mechanisms (l4,l5,l6,l7). Depression of
natural killer cell activity, antibody production and delayed hypersensitivity
responses can occur after exposure to these agents (l8,l9,20). Thus, both
antigen specific and non-specific responsiveness can be deliberately altered.
It is now readily apparent that some environmental contaminants are
immunotoxic. For example, benzo(a)pyrene, a ubiquitous and potent carcinogen,
depresses humoral immunity in adult mice (2l); an effect which persists for at
least 3/4 of the adult life span if exposure occurs jn_utero (22). The
association of immunosuppression and carcinogenicity has been reported for a
number of compounds (23). Immunosuppression appears to precede tumor
induction, since decreased immunity has been observed during the entire latent
period between chemical exposure and the development of cancer in laboratory
animals (24,25). In contrast, exposure to non—carcinogenic forms of the same
compounds does not affect immunity (2l,23). These findings are in accord with
the theory of immunological surveillance which states that most malignant
cells are antigenically distinct from normal cells and are therefore
recognized and destroyed by the immune system; suppression of immune
surveillance will therefore likely result in an increased tumor incidence
(26). while this system as originally proposed has a number of shortcomings
(27), it has become obvious that tumor incidence is increased in patients
administered immunotoxic drugs to maintain tissue grafts (28). Furthermore,
fetal, neonatal and very agedanimals display reduced immunocompetence
compared to normal adult mice and are more susceptible to chemically-induced
tumors during these periods (29). It has also been determined in humans that
infectious diseases increase during chronic immunosuppression. Thus,
infection with bacteria (30), protozoa (3l) or nematodes (32,33) that are
usually well tolerated may become pathogenic or be fatal to the compromised
host.
There have been many attempts to determine whether experimental exposures
to environmental contaminants can reduce immune functions. To date, numerous
reports have shown this to be the case. For the sake of brevity, a
representative sample of these reports are summarized in Table 5.2. This
listing is by no means complete, either in the compounds tested or the assays
performed.
Immune system dysfunction in humans exposed to environmental contaminants
is not well documented. However, an anecdotal report indicates suppressed T-
and B-cell growth in Michigan dairy farmers exposed to polybrominated
biphenyl(PBB)-contaminated meat and dairy products (49). Likewise,
immunologic evaluation of patients with "oil disease", an acne-like skin «
disease due to polychlorinated biphenyl(PCB)—contaminated cooking oil in
Taiwan, revealed suppression of delayed hypersensitivity, T—cells and serum
immunoglobulin levels (49,50).
5.4 SUMMARY
The immune system is responsible for protecting the host from infectious
agents and has a role in resistance to cancer. Suppression of these
protective functions may result if cells are unable to either recognize or
respond properly to antigens. Immunosuppression may also result from lysis of
immune cells by toxic materials or drugs. Experimentally—induced immune
20
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TA
BL
E
5.
2
EFFECTS OF SELECTED
ENVIRONMENTAL
CONTAMINANTS 0N
IMMUNE FUNCTION OF
EXPERIMENTAL
ANIMALS
Function
of
DeTayed
Accessory
Host Resistance
to Cha11enge
With:
Agent
Hypersensitivity
T-ce115
B-ce115
CeTTs
Bacteria
Viruses
Protozoa
Nematode
Tumor CeTTE'
Reference
 
DiethyTstibestrOT
(DES)
T
T
T
+
T
-
-
T
T
34,35
2,3,7,8—Tetrach10rodibenzo-
T
T/NE
NE*
T
T
-
—
-
T
36,37
p
-
d
i
o
x
i
n
(
T
C
D
D
)
HexachIorobenzene
NE
NE
t/T
NE
T
—
T
T
T
38,39,40
PolychTOrinated
biphenyT
(PCB)
T
i
T
-
-
T
T
—
T
39,41,42,43
PoTybrominated
biphenyT
(PBB)
NE
T
T
NE
NE
-
—
-
—
44,45
Lead
T
T
NE
T/NE
T
T
-
—
—
46,47
Cadmium
-
T
+/T
i/T
T
T
T
—
—
48
T
—
decreased
+
-
increased
T/+
—
confiicting
reports
or
ce11
subpopuIation
differences
NE
-
not
effected
 
dysfunction
has
been
adequately
demonstrated
in
laboratory
animals
exposed
to
environmental
contaminants,
especially
when
exposure
occurs
during
development
and
maturation
of
the
immune
system.
Whether
or
not
these
laboratory
results
can
be
interpreted
as
indicative
of
possible
effects
following
human
exposures
is
unknown
since
many
laboratory
studes
have
utilized
dosage
levels
and
exposure
routes
that
are
unlikely,
at
best,
to
occur
during
human
occupational
or
environmental
exposure.
Nonetheless,
alteration
of
the
human
immune
system
has
been
demonstrated
after
chemical
exposure
and
the
results
of
immunoassays
were
similar
to
those
obtained
in
animal
studies
(e.g.
see
44,45,49,50).
Occupational
exposure
to
certain
chemical
compounds
(e.g.
benzene)
has
been
associated
with
the
development
of
human
malignancy
(51)
and
in
animal
models,
with
immunosuppression
(52).
The
medical
profession
has
been
aware
of
the
potential
sequelae
which
may
follow
immunosuppressive
drug
therapy
and
therefore
monitor
patients
receiving
such
treatment
closely
to
detect
infection
or
cancer
development.
Since
the
therapeutic
goal
in
these
patients
is
to
significantly
reduce
the
immune
response,
usually
for
a
relatively
short
time,
levels
of
drug
administration
are
high
and
effects
on
the
immune
system
are
marked.
However,
exposure
to
potential
environmental
immunotoxicants
will
likely
be
at
levels
which
produce
immune
effects
with
chronic
exposure.
Therefore,
adequate
test
systems
for
low
level
chemical
exposure
need
to
be
developed
and
validated
so
that
their
results
may
be
rationally
extrapolated
to
the
human
population.
While
all
chemical
products
should
not
be
considered
for
screening,
those
that
are
likely
to
be
found
in
the
workplace
or
in
food,
water,
or
other
preparations
for
ultimate
human
consumption
should
receive
at
least
basic
evaluation
to
determine
immunotoxicity.
Immunotoxicologic
evaluation
of
their
products
is
at
present
a
routine
procedure
for
about
one
half
of
the
pharmaceutical
industry
(53).
This
approach,
while
providing
needed
safety
assessment,
may
also
provide
experimental
insight
into
immune
function,
disease,
disease
susceptibility
and
resistance
to
neoplasia.
5.5 RECOMMENDATIONS
l.
Adequate
test
systems
need
to
be
developed
to
measure
the
effects
on
the
immune
system
resulting
from
low
level,
chronic
exposure
to
chemicals.
2.
All
chemical
products
do
not
need
to
be
tested
for
immunotoxicity.
However,
at
least
basic
evaluation
for
potential
effects
on
the
immune
system
should
be
carried
out
on
those
chemicals
for
which
there
will
be
significant human exposure.
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6.] INTRODUCTION
Surveillance
and
monitoring
programs
of
contaminants
in
fish
and
water
provide
large
amounts
of
data
annually
for
a
variety
of
purposes;
however,
the
type,
quantity
and
quality
of
the
data
have
not
always
been
adequate
for
assessing
the
impact
of
these
contaminants
on
human
health.
The
Committee
on
the
Assessment
of
Human
Health
Effects
of
Great
Lakes
Water
Quality
emphasized
in
its
l98l
Report
the
need
to
consider
the
specific
data
required
from
these
programs
to
evaluate
health
impact.
A
Roundtable
was
convened
on
March
l7—l8,
l982,
to
address
this
topic
and
resulted
in
the
preparation
of
the
proceedings
of
the
"Roundtable
on
The
Surveillance
and
Monitoring
Requirements
for
Assessing
Human
Health
Hazards
Posed
by
Contaminants
in
the
Great
Lakes
Basin
Ecosystem".
To
reduce
ambiguity,
surveillance
was
defined
as:
"the
repeated
measurement
of
a
variable
in
order
that
a
trend
may
be
established”.
Monitoring
was
defined
as:
"the
measurement
of
a
fixed
variable
chosen
to
provide
data
on
how
well
regulations
are
working
and
how
far
standards
are
being
met."
Surveillance
was
deemed
to
include
annual
quantitation
of
well
known,
.e.,
"old"
contaminants
and
the
identification
of
previously
undetected,
.e.,
"new"
contaminants.
Monitoring
was
considered
in
terms
of
compliance
e.g.
the
determination
of
levels
of
contaminants
for
which
guidelines
or
standards
have
been
established)
in
commercial
and
sport
fish
or
finished
drinking water.
1'
1.
(
Although the scope of this Roundtable was limited to a consideration
of
programs pertaining to chemical
contaminants
in fish and water and to
microbiological
contaminants
in water,
Roundtable
participants
emphasized
the
need for data on contaminants present in air and in food.
Comprehensive human
health
impact
assessments
must
consider
the
total
exposure.
6.2
EXISTING
SURVEILLANCE
AND
MONITORING
PROGRAMS.
 
Extensive
surveillance
and
monitoring
programs
exist
or have
been
proposed
through
a variety
of federal,
state,
provincial
or
international
agencies
with
jurisdictions
on
or surrounding
the Great
Lakes.
The
development
of
these
programs has been closely tied to the Great Lakes International Surveillance
Plan
(GLISP),
a detailed
document
prepared
by the
International
Joint
Commission as required by the l978 Water Quality Agreement between the United
States and Canada.
In general, programs have been redesigned to meet changing
requirements; however, current fiscal restraint has dramatically reduced the
depth and utility of some programs and prevented the implementation of others.
Summaries of surveillance and monitoring programs of the jurisdictions are
presented in the proceedings.
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 6.3 GENERAL THEMES
Several
recurrent
themes
surfaced
during
the
Roundtable
deliberations
and
later
during
the
preparation
of
the
proceedings.
0
These are noted below.
Chemical
Surveillance.
Unlike
compliance
monitoring,
which
serves
the
mandate
of
each
specific
jurisdiction,
surveillance
is
required
to
serve
a
more
general
need.
Surveillance
must
meet
the
needs
of
the
future,
through
establishing
trends
in
chemical
concentration
and
by
identifying
emerging
problems.
More
emphasis
must
be
placed
on
surveillance programs.
 
Compliance
monitoring.
Generally
adequate
compliance
monitoring
of
fish
and
water
exists
in
the
basin;
programs
conducted
by
New
York
State
and
the
Province
of
Ontario
are
especially
comprehensive.
Interagency
cooperation
and
coordination.
More
discussion
among
the
jurisdictions
of
program
objectives
and
logistics
is
warranted.
Coordination
of
sampling,
analytical
and
assessment
methodologies
could
be
increased.
Benefits
would
include
implementation
of
more
effective
and
comprehensive
programs
and
sharing
of
research
loads.
This
theme
is
especially
relevant
to
surveillance
programs.
Comparability
of
data.
A
major
flaw
with
existing
programs
stems
fran
the
lack
of
comparability
of
data
collected
by
individual
agencies.
While
the
sampling
network
provides
extensive
coverage
of
the
Great
Lakes
Basin,
differences
in
time
of
sample
collection,
variation
in
portions
of
fish
analysed,
non-standardized
presentation
of
data
and
inadequate
quality
assurance
prevent
the
development
of
a
clear
picture
of
contaminant
levels
and
trends
thoughout
the
basin.
Comparability
of
data
is
especially
critical
for
surveillance
programs.
Data
reporting.
Summary
reports
of
surveillance
data
collected
from
fish
and
water
sampling
programs
are
rarely
exchanged
on
a
routine
basis
between
jurisdictions.
Clearly
formated
data
with
details
of
their
origin
are
urgently
needed
annually
and
especially
by
the
Health
Effects
Committee
of
the
International
Joint
Commission.
The
special
need
for
better
reporting
of
waterborne
disease
outbreaks
is
also
emphasized
at
the
Roundtable.
Objectives
of
health
hazard
assessments.
Two
distinct
approaches
to
health
assessment
emerge,
each
based
on
a
different
program
objective.
Some
agencies
require
prediction
of
toxic
levels
of
contaminants
in
order
to
issue
consumption
guidelines
to
the
public
for
fish
and
water
and
to
analyze
fish
and
water
for
compliance
with
these
levels.
Other
agencies
assess
the
current
health
impact
or
estimate
the
health
risk
for
populations
using
data
on
existing
contaminant
levels
in
fish
and
water
and
consumption
patterns.
Both
objectives
are
valid;
however,
the
second
objective,
requires
the
collection
of
more
detailed
consumption
figures
before
it
can
be
used
to
identify
populations
or
sub-populations
at
risk.
 0
Basic
research
and
evaluation.
The
need
for
a
vibrant
basic
research
program
was
frequently
emphasized.
Furthermore,
an
annual
meeting
at
the
scientific
level
was
recommended
in
order
that
the
results
of
research
and
surveillance
programs
coulo
be
adequately
evaluated
and
decisions
made
on
the
need
for
change
and
new
directions.
0
Agreement
on
intervention
levels.
Public
confidence
would
be
considerably
enhanced
if
the
jurisdictions
accepted
common
guidelines
or
invention
levels
for
contaminants
in
fish
and
water.
A
stumbling
block
to
such
progress
still
seems
to
be
the
uncertainty
over
contaminant
interactions
in
the
environment.
6.4 SPECIFIC DATA REQUIREMENTS
 
The
specific
data
required
of
surveillance
and
monitoring
programs
that
will
enable
more
adequate
health
assessment
to
be
conducted
and
the
conditions
for
its
generation,
were
considered
in
detail
at
the
Roundtable.
These
specific
requirements
for
data
from
programs
that
sample
chemical
contaminants
in
fish
and
water
and
microbial
contaminants
in
water
are
too
numerous
to
summarize
here;
hence,
they
have
been
provided
in
Appendix
l of
this
report.
6.5 FUTURE CONSIDERATIONS
Several
topics
related
to
the
specific
objectives
of
the
Roundtable
require future consideration:
0
comprehensive health impact assessments can only be conducted when
adequate
data
from
food
and
air monitoring
programs
become
available.
The
data
required
from
fooo
and
air
surveillance
programs
must be carefully considered;
0
access
to
up-to-date
industrial
production
and
use
data
would
be
extremely
useful
in
assessing
the
potential
for
human
exposure
to
chemicals.
Furthermore,
the
identification
of
a
central
clearing
house for information of this type for the heavily industrialized
Great Lakes Basin should be considered;
0
the usefulness of the surveillance of contaminant levels in human
tissues requires
evaluation.
The benefits for prioritization of
research are likely to be significant;
however,
implementation of
such programs requires the cooperation of the public, professional
groups and the jurisdictions; and
0
future consideration must be given to the design and implementation
of sensitive epidemiological surveys (eg. case control studies and
cohort studies) to determine the impact on human health and
reproduction of exposure to contaminants in the Great Lakes Basin.
6.6 CONCLUSIONS
Consideration of public health impact as a rationale for sampling fish and
water does not imply that existing surveillance and monitoring programs be
changed. Rather, it implies re-evaluation of existing programs designed, in
part, to provide data suitable for health hazard evaluation. The specific
requirements detailed in the proceedings of the Roundtable provided in
Appendix 1 of this report are the basis for such a re-evaluation.
29
 
 D
e
v
e
l
o
p
m
e
n
t
o
f
s
u
r
v
e
i
l
l
a
n
c
e
d
a
t
a
o
n
t
h
o
s
e
c
h
e
m
i
c
a
l
s
l
i
s
t
e
d
in
T
a
b
l
e
7
.
3
o
f
t
h
e
C
o
m
m
i
t
t
e
e
'
s
1
9
8
2
R
e
p
o
r
t
a
n
d
s
e
l
e
c
t
e
d
c
h
e
m
i
c
a
l
s
in
T
a
b
l
e
7
.
5
(
s
e
e
C
h
a
p
t
e
r
7)
w
i
l
l
b
e
e
x
t
r
e
m
e
l
y
u
s
e
f
u
l
t
o
a
g
e
n
c
i
e
s
i
n
v
o
l
v
e
d
in
t
h
e
a
s
s
e
s
s
m
e
n
t
o
f
t
h
e
i
m
p
a
c
t
o
n
h
u
m
a
n
h
e
a
l
t
h
o
f
c
o
n
t
a
m
i
n
a
n
t
s
i
n
t
h
e
G
r
e
a
t
L
a
k
e
s
b
a
s
i
n
.
6.7 RECOMMENDATIONS
General
I
t
i
s
r
e
c
o
m
m
e
n
d
e
d
t
h
a
t
t
h
e
j
u
r
i
s
d
i
c
t
i
o
n
s
o
f
t
h
e
G
r
e
a
t
L
a
k
e
s
B
a
s
i
n
:
l.
 
5.
r
e
c
o
g
n
i
z
e
t
h
e
n
e
e
d
t
o
a
s
s
e
s
s
t
h
e
c
h
r
o
n
i
c
h
e
a
l
t
h
i
m
p
l
i
c
a
t
i
o
n
s
a
n
d
i
m
p
a
c
t
o
n
r
e
p
r
o
d
u
c
t
i
o
n
o
f
l
o
w
l
e
v
e
l
e
x
p
o
s
u
r
e
o
f
r
e
s
i
d
e
n
t
s
o
f
t
h
e
G
r
e
a
t
L
a
k
e
s
B
a
s
i
n
t
o
e
n
v
i
r
o
n
m
e
n
t
a
l
c
h
e
m
i
c
a
l
s
;
i
n
c
r
e
a
s
e
t
h
e
c
o
m
p
a
r
a
b
i
l
i
t
y
o
f
t
h
e
i
r
d
a
t
a
b
y
:
(a)
m
o
r
e
f
r
e
q
u
e
n
t
i
n
t
e
r
a
g
e
n
c
y
c
o
m
m
u
n
i
c
a
t
i
o
n
a
n
d
r
e
v
i
e
w
o
f
s
a
m
p
l
i
n
g
,
a
n
a
l
y
t
i
c
a
l
a
n
d
a
s
s
e
s
s
m
e
n
t
m
e
t
h
o
d
o
l
o
g
i
e
s
;
a
n
d
(b)
i
m
p
l
e
m
e
n
t
i
n
g
q
u
a
l
i
t
y
a
s
s
u
r
a
n
c
e
p
r
o
g
r
a
m
s
;
(
a
)
r
e
p
o
r
t
t
o
t
h
e
I
J
C
a
t
l
e
a
s
t
a
n
n
u
a
l
l
y
t
h
e
f
i
n
d
i
n
g
s
o
f
s
u
r
v
e
i
l
l
a
n
c
e
a
n
d
m
o
n
i
t
o
r
i
n
g
p
r
o
g
r
a
m
s
on
t
h
e
G
r
e
a
t
L
a
k
e
s
a
n
d
p
r
o
v
i
d
e
c
o
m
p
l
e
t
e
d
e
t
a
i
l
s
o
f
s
a
m
p
l
e
c
o
l
l
e
c
t
i
o
n
,
h
a
n
d
l
i
n
g
a
n
d
a
n
a
l
y
s
i
s
;
a
n
d
(b)
m
e
e
t
a
n
n
u
a
l
l
y
to
d
i
s
c
u
s
s
t
h
e
s
i
g
n
i
f
i
c
a
n
c
e
o
f
t
h
e
d
a
t
a
f
o
r
t
h
c
o
m
i
n
g
f
r
o
m
s
u
r
v
e
i
l
l
a
n
c
e
a
n
d
m
o
n
i
t
o
r
i
n
g
p
r
o
g
r
a
m
s
a
n
d
t
o
p
r
o
p
o
s
e
c
h
a
n
g
e
s
in
f
u
t
u
r
e
p
r
o
g
r
a
m
s
as
d
e
e
m
e
d
s
c
i
e
n
t
i
f
i
c
a
l
l
y
appropriate.
e
v
a
l
u
a
t
e
t
h
e
i
r
s
u
r
v
e
i
l
l
a
n
c
e
a
n
d
m
o
n
i
t
o
r
i
n
g
p
r
o
g
r
a
m
s
t
h
a
t
p
r
o
v
i
d
e
d
a
t
a
p
e
r
t
a
i
n
i
n
g
t
o
p
u
b
l
i
c
h
e
a
l
t
h
,
i
n
t
e
r
m
s
o
f
t
h
e
s
p
e
c
i
f
i
c
r
e
q
u
i
r
e
m
e
n
t
s
l
i
s
t
e
d
i
n
t
h
e
p
r
o
c
e
e
d
i
n
g
s
o
f
t
h
e
R
o
u
n
d
t
a
b
l
e
a
n
d
a
l
t
e
r
t
h
e
i
r
p
r
o
g
r
a
m
s
as required.
S
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v
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c
e
a
n
d
M
o
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h
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d
W
a
t
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r
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o
r
O
r
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n
i
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n
d
I
n
o
r
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n
i
c
Chemicals:
I
t
i
s
r
e
c
o
m
m
e
n
d
e
d
t
h
a
t
t
h
e
j
u
r
i
s
d
i
c
t
i
o
n
s
o
f
t
h
e
G
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s
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a
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i
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i
d
e
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e
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a
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e
l
y
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u
r
v
e
i
l
l
a
n
c
e
f
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r
t
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o
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e
c
h
e
m
i
c
a
l
s
i
d
e
n
t
i
f
i
e
d
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y
t
h
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o
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i
t
t
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e
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n
t
h
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e
n
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o
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H
u
m
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n
H
e
a
l
t
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E
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f
e
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n
T
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b
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7
.
3
o
f
i
t
s
1
9
8
2
R
e
p
o
r
t
b
u
t
n
o
t
t
o
t
h
e
e
x
c
l
u
s
i
o
n
o
f
t
h
o
s
e
l
i
s
t
e
d
i
n
T
a
b
l
e
7
.
5
o
f
t
h
e
l
9
8
2
R
e
p
o
r
t
;
a
d
d
r
e
s
s
t
h
e
i
s
s
u
e
o
f
t
h
e
h
u
m
a
n
h
e
a
l
t
h
i
m
p
a
c
t
o
f
c
h
e
m
i
c
a
l
s
i
n
d
r
i
n
k
i
n
g
w
a
t
e
r
;
.
a
)
c
o
n
d
u
c
t
c
o
m
p
l
i
a
n
c
e
m
o
n
i
t
o
r
i
n
g
p
r
o
g
r
a
m
s
o
f
c
o
m
m
e
r
c
i
a
l
a
n
d
s
p
o
r
t
f
i
s
h
s
p
e
c
i
e
s
c
a
u
g
h
t
f
o
r
c
o
n
s
u
m
p
t
i
o
n
;
a
n
d
b
)
a
u
g
m
e
n
t
s
u
r
v
e
i
l
l
a
n
c
e
p
r
o
g
r
a
m
s
f
o
r
t
h
e
i
d
e
n
t
i
f
i
c
a
t
i
o
n
o
f
“
n
e
w
”
c
h
e
m
i
c
a
l
s
a
n
d
t
h
e
d
e
t
e
r
m
i
n
a
t
i
o
n
o
f
t
r
e
n
d
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o
f
"
o
l
d
"
c
h
e
m
i
c
a
l
s
;
c
o
n
t
i
n
u
e
t
o
g
a
t
h
e
r
d
a
t
a
o
n
t
h
e
f
i
s
h
c
o
n
s
u
m
p
t
i
o
n
p
a
t
t
e
r
n
s
o
f
G
r
e
a
t
L
a
k
e
s
B
a
s
i
n
r
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s
i
d
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n
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s
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o
r
d
e
r
t
h
a
t
m
o
n
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t
o
r
i
n
g
p
r
o
g
r
a
m
s
c
a
n
b
e
t
a
i
l
o
r
e
d
t
o
m
e
e
t
c
o
n
s
u
m
p
t
i
o
n
p
a
t
t
e
r
n
s
a
n
d
h
e
a
l
t
h
r
i
s
k
a
s
s
e
s
s
m
e
n
t
s
b
e
b
a
s
e
d
o
n
s
o
u
n
d
e
x
p
o
s
u
r
e
f
i
g
u
r
e
s
;
a
n
d
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r
e
s
o
l
v
e
t
h
e
"
e
d
i
b
l
e
p
o
r
t
i
o
n
"
i
s
s
u
e
b
y
:
a
)
a
g
r
e
e
i
n
g
o
n
a
s
t
a
n
d
a
r
d
e
d
i
b
l
e
p
o
r
t
i
o
n
;
o
r
b
)
c
o
n
d
u
c
t
i
n
g
r
e
s
e
a
r
c
h
o
n
t
h
e
r
e
l
a
t
i
o
n
s
h
i
p
s
b
e
t
w
e
e
n
d
i
f
f
e
r
e
n
t
p
o
r
t
i
o
n
s
o
f
d
i
f
f
e
r
e
n
t
s
p
e
c
i
e
s
o
f
f
i
s
h
s
u
c
h
t
h
a
t
d
a
t
a
f
r
o
m
d
i
f
f
e
r
e
n
t
j
u
r
i
s
d
i
c
t
i
o
n
s
c
a
n
b
e
c
o
m
p
a
r
e
d
.
S
u
r
v
e
i
l
l
a
n
c
e
a
n
d
M
o
n
i
t
o
r
i
n
g
f
o
r
M
i
c
r
o
b
i
o
l
o
g
i
c
a
l
C
o
n
t
a
m
i
n
a
n
t
s
i
n
W
a
t
e
r
I
t
i
s
r
e
c
o
m
m
e
n
d
e
d
t
h
a
t
t
h
e
j
u
r
i
s
d
i
c
t
i
o
n
s
o
f
t
h
e
G
r
e
a
t
L
a
k
e
s
B
a
s
i
n
:
l
0
.
a)
i
m
p
r
o
v
e
t
h
e
i
r
r
e
p
o
r
t
i
n
g
o
f
w
a
t
e
r
b
o
r
n
e
d
i
s
e
a
s
e
o
u
t
b
r
e
a
k
s
;
a
n
d
b
)
m
o
n
i
t
o
r
,
m
o
r
e
f
r
e
q
u
e
n
t
l
y
,
e
f
f
l
u
e
n
t
d
i
s
c
h
a
r
g
e
s
i
n
a
r
e
a
s
w
h
e
r
e
w
a
t
e
r
b
o
r
n
e
d
i
s
e
a
s
e
o
u
t
b
r
e
a
k
s
h
a
v
e
o
c
c
u
r
r
e
d
;
l
l
.
i
n
v
e
s
t
i
g
a
t
e
t
h
e
h
a
z
a
r
d
t
o
h
e
a
l
t
h
o
f
b
a
t
h
i
n
g
w
a
t
e
r
s
b
y
:
a)
e
n
s
u
r
i
n
g
t
h
a
t
c
u
r
r
e
n
t
m
o
n
i
t
o
r
i
n
g
p
r
o
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r
a
m
s
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r
b
a
t
h
i
n
g
w
a
t
e
r
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r
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t
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l
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z
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h
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b
e
s
t
i
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d
i
c
a
t
o
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s
o
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c
o
n
t
a
m
i
n
a
t
i
o
n
;
b)
g
a
t
h
e
r
i
n
g
d
a
t
a
on
t
h
o
s
e
o
r
g
a
n
i
s
m
s
i
d
e
n
t
i
f
i
e
d
as
p
o
t
e
n
t
i
a
l
l
y
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s
e
f
u
l
i
n
d
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o
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i
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r
o
b
i
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l
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g
i
c
a
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c
o
n
t
a
m
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n
a
t
i
o
n
o
f
w
a
t
e
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;
a
n
d
c)
c
o
n
d
u
c
t
i
n
g
r
e
s
e
a
r
c
h
on
t
h
e
r
o
l
e
b
e
t
w
e
e
n
t
h
e
m
i
c
r
o
b
i
o
l
o
g
i
c
a
l
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y
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n
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r
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7.l INTRODUCTION
The
Human
Health
Effects
Committee
published
five
tables
in
its
l98l
Report
that
categorized
those
chemicals
listed
in
Appendix
E
of
the
l978
Great
Lakes
Water
Quality
Board
Report
by
their
acute
and
chronic
hazard
to
man.
The
hazard
evaluations
conducted
and
reported
by
the
Committee
pertained
exclusively
to
the
presence
of
these
chemicals
in
the
Great
Lakes
Basin
and
their
potential
to
impact
on
human
health.
'__—
The
Committee
concluded
that
the
evaluations
that
led
to
Tables
l
through
5
of
the
l98l
Report
should
not
be
construed
as
final;
changes
would
be
required
as
new
data
on
the
toxicity
of
these
chemicals,
their
use
and
levels
in
the
Great
Lakes
Basin
ecosystem
became
available.
The
Committee
also
considered
the
reported
concentration
of
the
chemical
in
the
ecosystem.
Consequently,
for
example,
because
of
its
properties,
a
given
chemical
may
be
hazardous
to
human
health
under
certain
exposure
situations,
but,
because
of
the
concentration
at
which
it
is
present
in
the
Great
Lakes
ecosystem,
the
potential
for
exposure
via
this
pathway
may
be
minimal.
The
chemical
may,
therefore
not
represent
a
hazard
to
human
health
under
present
circumstances
in
the
Great
Lakes
Basin
ecosystem
and
would
therefore
be
of
minimal
concern
for
such
purposes
as
conducting
Great
Lakes
surveillance
and
monitoring
activities.
It
should
be
recognized,
however,
that
some
environmental
impacts
can
occur
at
levels
far below
those
deemed
critical
for
human
health
concerns
and
surveillance
and
monitoring
may
be
desirable,
based
on
other
considerations.
For
1982,
the
Committee
has
updated
last
year's
tables
based
on
the
constructive
suggestions
of
many
reviewers.
The
five
basic
tables
remain
and
the
rationale
for
each
is
reiterated
below.
The
re-evaluation
involved
several aspects, including:
o
the
Committee
cross-checked
within
and
between
tables
for
double
listings
and
the
accuracy
of
chemical
names.
In
numerous
cases
chemicals
in
appendix
E
were
listed
twice
under
different
names
or
the
CAS
number
did
not
match
the
chemical;
o
the
Committee
re—evaluated
some
chemicals
in
Table
5
for
which
there
were
new
toxicity
data
or
reports
of
levels
in
the
environment;
0
the
Committee
grouped
all
chemicals
listed
in
Tables
2
through
5
into
chemical
classes.
In
this
way,
chemicals
of
the
same
class
but
in
different
tables
could
be
readily
observed.
In
addition,
certain
classes
of
compounds
emerged
about
which
the
Committee
felt
they
could
make
recommendations.
It
should
be
noted
that
the
findings
by
the
Health
Effects
Committee
do
not
in
any
way conflict
with
a jurisdiction's
regulatory strategy
for
a
chemical
which
it
considers
to
be
hazardous
to
human
health.
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 7.2 RESULTS OF UPDATING
Updated versions of the original five l98l tables are provided in this
chapter (Tables 7.l through 7.5). Minor changes in title reflect the
Committee's desire to reduce any ambiguity in the titles of last year's tables
and not a shift in the original rationale any of the tables. Descriptions of
the updated tables follow. The specific changes made in each table are
described below and in more detail in Appendix 2.
Table 7.l.
This table lists those chemicals that have been reported in the Great
Lakes Basin ecosystem which have the potential to impact on human health based
on their relatively high acute toxicity for mammals.
High levels of these
contaminants (resulting from spills, industrial discharges or excessive run
off) in local areas, such as water intake zones, recreational water sites or
underground water reservoirs, could be hazardous to human health.
There are only two significant changes in Table 7.l between the l98l and
l982 reports; dichloropropane has been deleted because its acute oral LD50
in the rat exceeds 500 mg/kg and kepone has been deleted because it has not
been found in the Great Lakes Basin.
Minor changes in the chemical names have
also been made.
Chemical Abstracts Service Registry (CAS) numbers are not
provided because all Table 7.1 chemicals appear in one of the following four
tables and are listed with their CAS numbers there.
Chemicals have not been
grouped into classes because the grouping by toxicity is more useful.
It is necessary to emphasize that some chemicals listed in Tables 7.4 and
7.5 may also be highly acutely toxic;
however, there are insufficient data to
assess their acute toxicity at this time.
Furthermore,
some chemicals not
originally identified
in Appendix E of the l978 Great Lakes Water Quality
Board Report, but present in the basin, may be highly acutely toxic.
Table 7.2.
This table
lists those chemicals
found in the Great Lakes Basin
ecosystem
that are known
to have long—term toxic effects
in mammals and that are
currently
subjected
to
regulatory monitoring
for health
reasons.
Phenols
and
inorganic chemicals such as iron, copper and manganese have not been listed
despite
the
fact
that
there
are
drinking
water
guidelines
in
existence.
These
guidelines are based
on aesthetic considerations
of taste,
colour or odour,
but
not
toxicity.
Nickel
does
not
appear
in Table
7.2
for
similar
reasons.
Nickel
should be considered for surveillance,
based on its potential health
impact;
however,
the
current
water
quality
objective
provided
by the
International
Joint Commission
is based upon
fish toxicity.
Nickel
appears in
Table 7.3.
Only
minor
changes
have
been
made
in
the
content
of
Table
7.2;
however,
the
format
has
been
altered.
All
chemicals
have
been
grouped
by classes.
This
arrangement
of
chemicals
makes
clear
the
emphasis
placed
on
the
setting
of health
guidelines for two groups, pesticides
and elemental
contaminants.
Table
7.2
also
identifies
the
types
of monitoring
guidelines
or
standards
in
effect or proposed for each chemical
and the CAS number.
Minor changes
include
the
grouping
of
chloroform
and
other
trihalomethanes
under
one
heading,
the addition of photomirex
(a degradation
product of mirex)
and small
changes in chemical names.
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 TABLE 7.1.
CHEMICALS FOUND IN THE GREAT LAKES WHICH MAY IMPACT
ON HUMAh HEALTH IN THE EVENT OF
HIGH LOCAL CONTAMINATION*
Extremely toxic chemicals (L050 <50 mg/kg)
Aldrin
Carbofuran
Dieldrin
2,3,7,8—Tetrachl0rodibenzodioxin (2,3,7,8,-TCDD)
Endosulfan
Endrin
Ethion
Methyl mercury (chloride)
Oxychlordane
Toxaphene
1,1,2—Trichloro— 1,2,2-trifluoroethane
Very toxic chemicals (LDso 50—500 mg oral/kg)
Aniline
Bromochloroethane
Carbon disulphide
Chlordane
2-Chloroaniline
4—Chloroaniline
o—Cresol
DDT
Diazinon
1,2-Dibromoethane
1,2-Dichlorobenzene
2,3-Dichlorobutadiene
2,4-Dichlorophenoxyacetic acid (2,4—D)
1,3—Dichloropropene
2,3-Dichloropropene
Diphenylamine
N-Ethylaniline
Furfural
u—Hexachlorocyclohexane
y—Hexachlorocyclocyclohexane (Lindane)
Hexachlorobutadiene
Mirex
Pentachlorophenol
Phenol
Photomirex
Tetrachloroethane**
1,1,2,3-Tetrachloropropene
2,4,5—Trichlorophenoxyacetic acid (2,4,5-T)
Vinyl Bromide
Vinyl Chloride
Elements which form toxic compounds (LDso <500 mg oral/kg.)
Arsenic (trioxide3+l
Cadmium (chloride)
Cobalt (cobaltou52+)
Lead (alkyl4+)
Mercury (elementalol
Nickel (acetate2+)
Silver (nitrate3+)
Vanadium (trioxide3+)
 
* Based on acute oral exposure in rats. Principal data base:
NIOSH Registry of Toxic Effects of Chemical Substances, 1979, USHHS.
** Unspecified isomer(s)
35
 
 TABLE 7.2
CHEMICALS FOUND IN THE GREAT LAKES WITH KNOWN EFFECTS IN MAMMALS
THAT ARE CURRENTLY SUBJECTED TO REGULATORY MONITORING*
 
CHEMICAL NAME CAS NO. MONITORING PROCRAM**
PESTICIDES
ATdrin 309—00—2 DN F NQO
ChTordane (totaT isomers) 57-74—9 DN F NQO
2,4-DichTorophenoxyacetic acid(2,4-D) 94-75-7 DN
DDT (DDE, 72-55-9 and DDD, 75-54-8) 50—29—3 DN F NQO
Diazinon 333—41-5 DN
Dierrin 60—57-1 DN F NQO
Endrin 72-20—8 DN F NQO
HeptachTor 76-44-8 Dw NQO
HeptachTor epoxide 1024-57-3 DN NQO
Lindane (y-hexachTorocycTohexane) 58-89-9 Dw NQO
MethoxychTor 72-43-5 DN NQO
Mirex (and photomirex, 39801-14-4) 2385-85—5 F NQO
Silvex 93-72-1 DN
Toxaphene 8001—35—2 DN F NQO
HALOGENATED HYDROCARBONS
PoTychTorinated biphenyTs 1336-36—3 F NQO
TrihaTomethane (chToroform) 67-66-03 DN
(bromoform) 75—25-2
(bromodichToromethane) 75—27-4
(chTorodibromomethane) 124-48-1
(iododichToromethane) 594—04-7
ELEMENTS
Arsenic 7440-38-2 DN F NQO
Cadium 7440—43-9 DN NQO
Chromium 7440-47—3 DN NQO
Lead 7439-92-1 DN NQO
Mercury (methyT) 115-09-3 Dw F NQO
SeTenium 7782—49-2 NQO WOO-P
SiTver 7440-22-4 DN NQO-P
ETHERS
2,3,7,8-TetrachTorodibenzodioxin 1746—01-6 F
* Monitoring based on concern for human heaTth.
** DN — United States or Canadian drinking water guideTine or standard
F
- GuideTine for acceptabTe TeveTs in fish (heaTth protection)
WOO
- Nater QuaTity Objective in Annex 1 of the 1978 Great Lakes Nater
QuaTity Agreement
NQO-P
- Water QuaTity Objective proposed by the Aquatic Ecosystems Objectives
Committee, IJC Science Advisory Board
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 Table 7.3.
Chemicals
found
in
the
Great
Lakes
Basin
ecosystem
that
have
the
potential
to
impact
on
human
health
because
of
known
long-term
toxic
effects
on
mammals
and
their
use,
release
or
appearance
in
the
basin,
are
listed
in
Table
7.3.
The
Committee
recommends
that
these
compounds
be
considered
for
inclusion
in
surveillance
programs;
the
type
of
surveillance
recommended
by
the
Committee
is provided in this year's table.
Changes
to
Table
7.3
include
the
addition
of
several
chemicals
(benzo
(b)-
and
benzo
(j) fluoranthene,
cresol,
l,2—dichloroethylene,
and
endosulfan)
the
grouping
of
all
chemicals
by class
and minor
changes
to
headings
and
chemical
names.
Summary evaluations
and the bases for surveillance for most chemicals
are
provided
in
the
Committee's
l98l
report
and
are
not
reproduced
here.
Summary evaluations for chemicals
added this
year are provided
in Appendix 3.
Data
forthcoming from
surveillance
programs
that
have
attempted
to
identify and quantify these chemicals must be carefully evaluated.
Continued
surveillance may not be warranted
if levels are exceedingly low, declining, or
if industrial
use patterns
indicate declining consumption.
Table 7.4.
Table 7.4 lists those chemicals
found in the Great Lakes Basin
ecosystem
that are of minimal current concern from the human health perspective.
This
assessment is based on an evaluation of all existing data on toxicity use and
environmental levels.
There are numerous additions and corrections made to
Table 7.4 as a result of a careful auditing exercise that identified several
multiple listings of the same chemical by different names and a re—evaluation
of Table 7.5 compounds.
The specific changes and the rationale for the
changes are presented in Appendix 2 of this report.
For consistency, Table
7.4 has also been organized into chemical classes and CAS numbers have been
added.
Table 7.5.
Those chemicals found in the Great Lakes Basin ecosystem for which there
are insufficient data to conduct a health hazard assessment, are listed in
Table 7.5.
The chemicals
listed have either insufficient toxicity data or too
few details of their use, release or levels in the basin. Some of these
chemicals may prove to be toxic to mammals in future studies.
Partial reconsideration of the chemicals listed in Table 5 of the l98l
Report has resulted in a large number of deletions. Some chemicals were
previously listed in other tables by different names, others have been
re-evaluated using new data and moved to other tables. The changes and
accompanying rationale are given in Appendix 2. Summary evaluations for
several compounds appear in Appendix 2.
Chemicals appearing in Table 7.5 should not be excluded from consideration
for surveillance. Determination of the levels of these chemicals in the Great
Lakes Basin ecosystem would aid the assessment process greatly. Research
efforts should be directed toward compounds in Table 7.5 which have or are
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likely to have significant long—term toxic effects on mammals. The pesticides
listed have well defined toxic properties; however, their levels in the
environment are poorly documented. The toxic properties and the environmental
distribution of the chemicals in the halogenated hydrocarbon group, the
aromatic hydrocarbons and the ethers are poorly characterized.
Some groups of chemicals in Table 7.5 are of low priority for further
research and data gathering. Terpenes are naturally occurring organic
chemicals in plants that are likely to be ubiquitous. Little is known of
their specific toxicology or their levels in drinking water and fish.
Although there are currently insufficient exposure and toxicity data to move
the terpenes into Table 7.4, they should be considered a low priority for
further work.
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 TABLE 7.3
CHEMICALS FOUND IN THE GREAT LAKES WITH THE POTENTIAL TO IMPACT ON
HEALTH THAT ARE NOT CURRENTLY SUBJECT TO REGULATORY MONITORINC
BUT FOR WHICH SURVEILLANCE SHOULD BE CONSIDERED* ~1982
  
SURVEILLANCE RECOli‘JilENDEDH
 
CHEMICAL NAME
CA5 N0.
HATER
FISH
AIR
PESTICIDES
Endosulfan (thiosulfan)
115-29-7
NS
NL
Hexachlorobenzene
118-74—1
NL
Oxychlordane+
26880—48-8
NS
NL
Pentachlorophenol
87-86-5
NS
WL;NS
2,4,5—Trichlorophenoxy acetic
acid (2,4,5—T) 93-76—5 NS NL
HALOGENATED HYDROCARBONS
Carbon tetrachlcride 50—23—5 ID;NS ML
1,2-Dichloroethane
107-06-2
ID;NS
NL
A
1,2-Dibromoethane
106v93—4
NL
A
Hexachloroethane 67-72-1 NS NL
1,2-Dichloroethylene 540-59-0 ID;NS
Trichloroethylene 79—01—6 NS NL
Tetrachlorocthylene 127-18-4 ID NL
Vinyl chloride
75—01-4
ID
NL
A
Vinyl bromide
593—60—2
ID
NL
A
3—Chloro-I—propene 107—05-1 ID
2,3-Dichlorobutadiene 1653~19-6 ID;NS NL
Hexachlorobutadiene 87—68—3 NS NL
Dichlorobenzene (1,2—) SS—SO—I NS NL
(1,3-) 541—73—1
(I,4-) 106-46-1
a-Hexachlorocyclohexane 319-84-6 NL
Chlorinated naphthalenes NS NL
Brominated biphenyls NS NL
Chlorinated terphenyls NS NL
ARDMATIC HYDROCARBONS
Ethylbenzene 100—41—4 NS
Styrene 100-42-5 NS HL
Benzo(a)pyrene 50—32-8 NS ML A
Chrysene 218-01-9 NS NL A
Dibenz(a,h)anthracene 53-70-3 NS NL A
Benzo(b)fluoranthene 205—99-2 NS HL A
Benzo(J)fluoranthene 205-82—3 NS HL A
PHENOLS
Cresol+ (o,m,p) l319—77—3 ID,NS
Trichlorophenol+ (2,4,5-) 95-95—4 NS NL
(2,4.6-) 88-06-2
ETHERS
Dioxane l23-9l-l ID;NS NL;NS
ACIDS AND ESTERS
Phthalic acid, aiisobutyl ester 84-69-5 NL
Phthalic acid, di(2-ethylhexyl)
ester ll7-8l-7 HL
MISCELLANEOUS
Aniline 62-53—3 ID
Azobenzene l03-33-3 ID
3,3'—Dichlorobenzidine 9l-94-l ID
ELEMENTS
Nickel 7440—02-0 ID A,ID
* ‘Potential to impact on health' based on all available data on toxicity.
use and environmental levels.
** ID — industrial discharges
NL - Hhole lake
NS - Near shore
A - Ambient
+ covered under parent compound in some jurisdictional guidelines.
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 TABLE 7.4
CHEMICALS FOUND IN THE GREAT LAKES 0F MINIMAL CURRENT
LONCERN FROM A HUMAN HEALTH PERSPECTIVE‘
CHEMICAL NAME
CAS N0.
CHEMICAL NAME
CA5 NO.
PESTICIDES
ALDEHYDES
Atrazine
1912-24-9
Formaldehyde
50—00—0
Carbofuran
1562—66-0
Vanillin
121-33—5
Biomba 1918—00-9
Ethion
563—12-2
KETONES
Leptophos 21609-90-5
Malathion
121-75-5
Acetone
67-64-1
MCPA (4-chloro-o-toloxy acetic acid)
94—74-6
Z-Butanone
78—93-3
3-Pentanone 96—22-0
ALIPHATIC HYDROCARBONS
Acetophenone
98—86-2
4-Methyl-2-pentanone 108-10—1
Butane 106-97-8
Butane (1-)
106-98-9
ETHERS
(2-) 107-01-7
1,3-Butadiene
106-99—0
Diethyl ether
60-29—7
1-Buten~3-yne
689—97-4
Diisopropyl ether
108—20-3
Pentane
109-66-0
Safrole
94‘59-7
Neopentane 463-82-1
Cyclopentane
287-92-3
ACIDS AND ESTERS
Pentene (1-)
109-57-1
(2-)
109-684
Methacrylic acid, methyl ester
80-62-6
Hexane
110—54-3
2-Methylpentanoic acid
97-614)
Cyclohexane
110-82-7
Hexanoic acid (Caproic acid)
1412-62-1
Heptene
25339-564
Hexanedioic acid. dimethyl ester
Hexene
25264-93-1
(Diniethyl adipate)
627—93-0
Nonene
27215-95—8
Hexanedioic acid, dihexyl ester
2,5-Dimethyldecane
17312-50-4
(Dihexyl adipate)
110-33-8
2,6-Diuiethylundecane
17301—23-4
Heptanoic acid (Enanthic acid)
111-14-8
Tetradecane
629-59-4
Octanoic acid (Caprylic acid)
124-07—2
Tetradecene
1120-36-1
Z—Ethylhexanoic acid, methyl ester
816-19-3
Hexadecane
544-76-3
Nonanoic acid (Pelargonic acid)
112-05-0
Decylcyclohexane
1795-16-0
Decanoic acid (Capric acid)
334-48-5
Heptadecane
629-78-7
Dodecanoic acid (Lauric acid)
1433-07—7
lO-Methyleicosane
55193-56—1
Dodecanoic acid, methyl ester
Tetracosane
646-31-1
(Methyl laurate)
111-82-0
Tetradecanoic acid (Myristic acid) 544-63—8
HALOGENATED HYDROCARBONS
Tetradecanoic acid, methyl ester
(Methyl myristate) 124-10-7
Dichloromethane
75-09-2
Pentadecanoic acid
1002—84-2
Dichlorodifluoromethane
75—7l-8
Hexadecanoic acid, methyl ester
Trichlorofluormethane
75-69-4
(Methyl palmitate)
112—39-0
Dichlorobromofluorwethane
353-58-2
Hexadecanoic acid, ethyi ester
1,1,l-lrichloroethane
71-55-6
{any} pa‘mitate)
523-974
1aliz-TT‘ICMOTO-lﬂiz-tr)fluoroethane
76'13-1
Hexadecanoic acid (Palmitic acid)
57—10-3
9-Hexadecanoic acid (Palmitoleic acid) 2091-29-4
AROMATIC HYDROCARBONS
Heptadecanoic acid (Margaric acid)
506-12-7
Octadecanoic acid, methyl ester
Benzene
71-43-2
(Methyl stearate)
112-6143
TOWERS
108-88'3
9,10-Dihydroxyoctadecanoic acid, methyl ester
1115—01-1
XYlene (0-)
95-47-6
9-0ctadecenoic acid (cis)(Oleic acid)
112-80-1
(l')
108-35-3
9~0ctadecenoic acid, methyl ester (trans)
1937-62-8
(9‘)
106-42'3
(Methyl elaidate)
Propylbenzene
103-65-1
9,12-0ctadecadienoic acid (Linoleic acid)
60—33—3
CW"!
98-82'8
9,12,15-0ctadecatrienoic acid, methyl ester
Propyltoluene
28729-54-6
(Methyl linolenate)
301-00-8
Diethylbenzene
25340-17-4
Z-Methyloctadecanoic acid
7217-83—6
Naphthalem
91'20'3
Eicosanoic acid (Arachidic acid)
506-30-9
l,2-Dihydro-6-Iuethylnaphthalene
2717-47-7
“commit acid, Methyl ester
Biphenyl
92-52-4
(Methyl arachidate)
1120-28-1
Di-ethylbiphenyl
28013—11-8
Docosanoic acid (Behenic acid)
112-85-6
kenlphtheﬂe
83-32'9
Tetracosanoic acid (Lignoceric acid)
557-59-5
Diphenylmethane
101-81-5
Benzoic acid
65-85-0
Fluorene
86-73-7
Salicylic acid
69-72-7
Anthracene
120-12-7
Phthalic acid, dibutyl ester
84-74-2
"G‘Mlin‘hraCE'Ie (1')
510-43'0
Phthalic acid, butyl ester, ester with
(2-)
613-12-7
butylglycolate
85-70-1
(9-) 779-02-2
Phenanthrene
85-01-8
pHENoLs
Hethylphenanthrene
28652-81—5
—
HUOWNMM
206‘44'0
Guaiacol (methoxyphenol)
90-05-1
Pyrene
129-00-0
Phenol
108-95-2
Benzofluorene (l,2—) 238~84-6
(2,34
243-17-4
TERPENES
Benzanthrene
56—55-3
‘
Benzo(k)fluoranthene
207-08—9
Borneo]
50740-0
Perﬂene
193-55'0
Camphene
79-92-5
Coronene
191-07-1
Camphor
46449-3
Dibenzo(def,mno)chrysene
191-26-4
[sobomeoi
12445-5
Limonene
138-86-3
ALCOHOLS
Pinene (a-) 80—56-8
Propanol (1—)
71-23-8
(5.)
12741.33
(2-) 67-63—0
tert-Butanol
75-65-0
Temineo]
3000_41_7
Z-Buten-l-ol 6117-91-5
Z—Ethyl-l-hexanol
104-76-7
MISCELLANEOUS
1-Decanol 112-30-1
Tetradecanol
27196-00-5
Benzothiazole
95-16-9
l-Octadecanol
112-92-5
Caffeine
58-08-2
l-Dodecanol
112—53—8
Carbon disulfide
75-15-0
Benzyl alcohol
100-51-6
N,N-Dimethylaniline
121—69-7
ELEMENTS
Cobalt 7440-48-4
Copper 7440-50-8
Strontium 7440-24-6
Vanadium 7440—62-2
Zinc
7440-66—6
 
*
Based on all available data on toxicity, use and environmental levels.
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 TABLE 7.5.
ChEMICALS FOLND IN THE GREAT LAKES FOR HHICH THERE ARE INSUFFILIENT
DATA AVAILABLE TO CONDUCT A HEALTH HAZARD ASSESSMENT"
ChEMCAL NAME
CAS NO,
CHEMLAL NAME
CA5 N0.
PESTICIDES ETHERS
Alachlor
15972-60-8
Dimethoxymethane
109-87—5
Chloropyrifas
2921-88-2
Bis(2-chloroethyl) ether
111-44-4
Cyprazine
22936-86-3
Bis(2-chloroisopropyl) ether
108-60-1
Ethuron
15545-50—3
1,2-Diethoxyethane
629—14—1
EPTC (Eptan)
759-94-4
Trietlu'leneglycolethyl ether
112-50-5
Metribuzin
21087-64-9
4—Bromoanisole
104-92-7
Nonachlor
3734—49-4
Dichloroanisole
54518-15-9
Prometone
1610—18-0
Trichloroanisole (2,4,5-)
6130-75—2
Simazine
122-34-9
(2,4,6—)
87-40—1
Trifluralin
1582-09-8
2,4,6-Tribromoanisole
607—99-8
DMPA (Zytrun)
299-85-4
Tetrachloroanisole
53452—81—6
a,q,1,4,5-Pentachloroanisole 33104-17-5
HALOGENATED HYDROCARBONS Dichloromethoxyphenol .....
‘
2,4,6—Trichloro—3-methoxyphenol
26378—18—7
lermOmEthane 74-95-3 2,3,4,5-Tetrachloro-G-methoxypl.enol 2539—17-5
Ethyl chloride
75—00—3
4-Ch'loro-1,2-dimethoxybenzene
16766-27—1
l-Bromo-Zvchloroethane
107—04—0
1,2-DichlOrzo—4,5-dimethoxybenzene
2772-46-5
Dibromochloroethane
73506-944
1,2,3-Trichloro—4,S-dimethoxybenzene
16766—29—3
Pentachloroethane
76—01-7
Z—Methoxy-Il-propylphenol
2785-87-7
Trichloropropane (1,1.2-i 598-77-6 4-Methyi—2—ethy1-1,3-dioxoiane 4359-46-0
(1.2,2-) 3175-23—3 Dehyarodiconiferyl alcohol 4263-87-0
Pentachloropentane (l,1,2,3,3—)
15104-614
Tetrahydrofuran
109-99-9
(1.1.1,2,3-) 21700-31-2 Methyltetrahydrofuran 25265-68-3
(1,1,1,3,3-)
23153-23—3
Tetrahydropyran
142-68—7
Dichloro—l-propene 26952—23—8
Tetrachloroprcpene (1,3,3,3-)
15022-22-7
ACXDS AND ESTERS
(2,3,3.3-) 16500-91—7 —_
(l,l,3.3-) 18611-43-3 Phenylacetic acid 103-82-2
(1,2,3,3—)
20589—85—9
4-Hydroxy—3-methoxyphenylacetic acid
306-08-1
Dichlorobutane
26761-81-9
Phenylpropanoic acid (2-)
492-37-5
1,1,4,4,4-Pentachloro—l-butene
30353-54-9
(3-)
501-52-0
1,1,1,4,4,4-Hexachloro-Z-butene (trans)
18766—87—5
2-(4-Chlorophenoxy)-2-methylpropanoic acid
882—09—7
Tetrachlorobutadiene (1,1,2,3—)
921-09-5
2—(4—Chlorophenoxy)butanoic acid, methyl ester
69335~86—0
(l.1,3,4-) 1637—31-6 Phthalic acid, dimethyl ester 131-11-3
(l,2,3,4-) 18149-76—3 Phthalic acid, diethyl ester 84-66-2
Pentachlorobutadiene (l.l,2,3,4-)
5659-44—9
Phthalic acid, butylbenzyl ester
85-68~7
(l,1,2,4,4-) 21400-41-9 Phthalic acid, dioctyl ester 117-84-0
s —Hexachlorocyclohexane 319-85-7
Bromobenzene 108-86-1 PHENOLS
Chlorobenzene 108-90-7 _“
Trichlorobenzene (l,2,3—) 87-61—6 Chlorophenol (2-) 95-57-8
(1,2,4-l 120-82-1 - 108-43-0
Tetrachlorobenzene (1,2,3,4-)
634—66-2
(4-)
106-48-7
(1,2,3,5-) 634-90-2 Dichlorophenol (2,3-) 576-24-9
Pentachlorobenzene
608-93-5
(2,4-)
120-83-2
Chlorotoluene (2-) 95-49-8 (2.6-) 87-65-0
(3-) 108-41-8 (4,6-) 120-83-2
(4-) 106-43-4 2,3,4,6-Tetrachlorophenol 58-90-2
Tetrachlorotoluene (a,a,u,2—)
2136-89-2
o-Phenylphenol
90-43-7
u,a,u,4-) 5216-25-1 tert-Butylpyrocatechol 27213-784
(u,a,2,4-) 134‘25-8
(a,u,2.6-) 81—19-5 TERPENES AND DERIVATIVES
(u,2,3,6-) 1424-79-9
Pentachlorotoluene 877-11-2 Terpinene 8013-00-1
Pentabrunotoluene 87-83-2 Epijuvabione 26462—74-8
Chloroxylene 25323-41-5 l-Chloro-Z-norbornene 15019-71-3
Hexachlorostyrene ————— 1,2,3,4,7-Pentachloro-Z-norbornene (syn) 18317-90-3
a.a1,3,4,5,6-Heptachlorostyrene 29082-75-5 (anti) 21657-70-5
1.2,3,4-Tetrachloroanthracene 25283-02—7 Fencllyl alcohol 1632-73-1
Pimaric acid, methyl ester 3730-56-1
AROMATIC HYDROCARBONS Sandaracopimaric acid (lsodextropimaric acid) 23527-10-8
Sandaracopimaric acid, methyl ester 1686—54-0
Phenylacetylene 536-74-3 Isopimaric acid 5835-26—7
l-Isopropyl-3-methylbenzene 535-77-3 Isopimaric acid, methyl ester 1686-62-0
1—1sopropyl-4-methyltenzene 99-87-6 Abietic acid 514-10-3
Butylbenzene (n-l 104-51-8 Abietic acid, meth ester 127-25—3
(sec-) 135—98—8 Dehydroabietic acid 1740—19-8
(tart-i 86—06-6 Dehydroabietic acid, methyl ester 1235-74-1
Methylnaphthalene 1321-94—4 7-0xodehydroabietic acid 18684»55-4
Dimethylnaphthalene 28804-88-8 7-Oxodehydroabietic acid, methyl ester 17751-37-0
l-Phenylnaphthalene 605-02-7 Chlorodehydroabietic acid 22478-66-6
Terphenyl 26140-60-3 Clllorooxodeiwdroabietic acid 38012-02-1
Benzo(e)pyrene 192-97-2 Neoabietic acid, methyl ester 3310-97-2
Indeno(1,2,3,cd)pyrene 193-39-5 B -Sitosterol 83-46-5
Dibenzo(b,def)chrysene 189—64-0
Naphtho(1,2,3,4,def)chrysene ----- MISCELLANEOUS
Benzo(rst)pentaphene 189-55—9
Benzo(ghi)perylene 191-24-2 Dimethyl sulfide 75-18-3
Dimetlxyl disulfide 624-92—0
KETONES 1,3,5-Trithiolpentane 34202-58-9
1,2,S.6-Tetrathiolhexane 58510-13-7
Hethyl-tert—butyl ketone 7‘-97-8 Chloroaniline (2-) 95-51—2
2-Hydroxy-4-methoxyacetophenone 55241-0 (3-) 10542-9
2-Hydroxy-6-methoxyacetophenone 703—23-1 (4-) 106-47-8
2-Nydroxy-3-methoxyacetophenone 703-98-0 Trichlor‘oanlllne (2.4.5-) 636-30~5
Z~Hydroxy-5-nethoxyacetophenane 705-15-7 2 . 4 .5-) 034'93-5
4-Hydroxy-3-methoxyacetonhenone (Acetovanillone) 498-02-2 Pentachloroaniline 527-20-8
Dimethoxyacetophenone (2,4~) 5329—20-9 N-Etiwldnih'ﬂe 103-59'5
(2.5-) 1201-38-3 N.N-Diethylaniline 91-66-7
(2.6-) 2040-04-2 Z-Methylbensz)thiophene 1195—14-8
(3.“ 1131-62-0 6-Benzothiazolol 13599-84-3
2—Mechoxy-1-(4-metnomhenyi )ethanone
21160-26~9
G-Methyl—2-benzothiazolethiol
2268-79-3
2-Chloro-l-pheyul-l-propanone 6084-17-9 Chloroindole (2—) 694-93-9
4—Hydroxy-3-nethoxypropiophenone 1835-14-9 (34 15853-964)
Dichlorobenzophenone (Z,2'-) 5293-97—0 (4-) 25235-35-2
(3,3'—) 7094-34-0 (5-) 17522-32-1
4.4K) 90-98-2 (6-) 17422-33-2
1-(2,2',4'—irichloro[1,1'-3ipneny1]-4-y1)ethanone 39249-73-5 Trimethylisocyanurate 877-89—4
2.2—Dichloro-1-(2‘-Chloro[l,l'-Biphenyl]-4-yl)ethanone 59612-59-8 Triphenyl phosphate 115-86-6
Vanillone
575-23-7
Diphenylnonylphenyl phosphate
----
Diphevwlcmlylphenyl phosphate ----
ALDEHVDES Stilbene oxide 17619-97-5
Homovanillin 5703-24—2
u -Phenylbenzeneacetaldehyde 947-91-1
2-Chloro-u-Phenylbenzeneacetaldehyde 52999-73-2
2-Chloro—a—(Z-chlorophenyl )benzeneacetaldehyde) 51559-01-4
2—Chloro-a-(4—chlorophenyl )benzeneacetaldehyde 34877-75-3
4-Chloro-u-(4-chlorophenyl )benzeneaceta'l dehyde 18164-50-6
Syringaldehyde 134-96-3
Chlorosyringaldehyde -----
4] * Based on available data on toxicity, use and environmental levels.
 
 7.3 DISCUSSION
The Committee has endeavoured to clarify the content and purpose of the
lists of chemicals it published in l98l.
It has also conducted a partial
re-evaluation of some compounds and provided additional information to aid
those jurisdictions with responsibilities for surveillance and monitoring
programs.
No further evaluations of Appendix E chemicals or those listed
in
Tables 7.1 through 7.5, are forecast; however, the Committee will sustain its
‘
commitment to evaluate
the health implications of chemical
substances found
in
the Great Lakes Basin.
Emphasis should now be placed by the jurisdictions on
I
gathering surveillance
data for all chemicals
in Table 7.3 and some in Table
7.5 of this report and obtaining up-to—date quantity and use data from
industry.
7.4 RECOMMENDATIONS
The Committee recommends that:
l.
those chemicals
listed in Table 7.3 of this report
(1982) be
considered for immediate inclusion in surveillance programs and that
certain
groups
of
chemicals
listed
in Table
7.5
be
considered
as
candidates for surveillance programs of limited scope;
2.
a new
comprehensive
list
of chemical
substances
present
and
their
levels in the Great Lakes Basin ecosystem be prepared as soon as
possible and that it be coupled with up-to-date quantity and use data
for chemicals manufactured, used or released in the basin; and
3.
the
Parties
should
again
be
urged
to
develop
toxicity
information
for
the chemicals
in Table 7.5,
identified as contaminants
and/or in
widespread
use
in
the
Great
Lakes
Basin.
42
 
8. Recommendations
The
Committee
on
the
Assessment
of
Human
Health
Effects
of
Great
Lakes
Water
Quality
make
the
following
recommendations:
8.l
DRINKING
WATER
AND
PUBLIC
HEALTH
CONCERNS
C
D
Chemical
Surveillance
of
drinking
water
supplies
for
new
organic
contaminants
must
be increased.
The
Parties
should
augment
present
toxicology
programs
to
study
the
toxicity
(including
carcinogenicity)
of
chemicals
identified
in
drinking
water
supplies
within
the
Great
Lakes
Basin.
More
emphasis
should
be
placed
on
toxicity/mutagenicity
studies
of
the
non-chlorinated
organic
chemical
fraction
from
drinking
water.
Microbiological
Modification
of
drinking
water
treatment
plant
operations
should
be
undertaken
with
caution
and
on
an
individual
basis
following
adequate
studies to determine:
a)
the
efficacy
of
the
modified
treatment
process
in
removing
contaminants of concern; and
b)
the
impact
of
the
microbiological
quality
of
the
product
water
both
at
the
plant,
and
more
importantly,
in
the
distribution
system.
Point-of-use
water
treatment
units
should
be
used
only
where
conventional
approaches
are
not
applicable
and
then
only
with
an
adequate
monitoring
program
and
regeneration/replacement
schedule.
Additional
research
into
the
relationship
between
particulate
matter/turbidity
and
waterborne
illness,
especially
in
recreational
waters,
be
undertaken
to
determine
whether
improved
particulate
removal
during
sewage
and
stormwater
treatment
should
be
recommended.
Jurisdictions
should
be
urged
to
recognize
the
need
for
the
assessment
of
chronic
health
problems
from
low
level
exposure
to
microbiological
contaminants.
.2
RECREATIONAL
WATER
QUALITY
 
l.
A
more
rational
basis
for
out
understanding
of
health
risks
from
swimming
should
be
obtained
through
additional
research.
It
appears
that
safe
waters
for
swimming
can
be
provided
without
excessive
reliance
on
the
chemical
disinfection
of
wastewater
effluents.
.3 IMMUNOTOXICITY
l.
Adequate
test
systems
need
to
be
developed
to
measure
the
effects
on
the
immune
system
resulting
from
low
level,
chronic
exposure
to
chemicals.
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 A11
chemical
products
do
not
need
to
be
tested
for
immunotoxicity.
However,
at
least
basic
evaluation
for
potential
effects
on
the
immune system should be carried out on those chemicals for which
there
will
be
significant
human
exposure.
8.4 ROUNDTABLE ON DATA REQUIREMENTS FROM SURVEILLANCE AND MONITORING PROGRAMS
General
It
is
recommended
that
the
jurisdictions
of
the
Great
Lakes
Basin:
1.
recognize
the need
to
assess
the
chronic
health
implications
and the
impact on
reproduction
of
low
level
exposure
of residents
of the
Great Lakes Basin to environmental chemicals;
increase
the
comparability
of their
data
by:
a)
more
frequent
interagency
communication
and review
of
sampling,
analytical
and
assessment
methodologies;
and
b)
implementing
quality
assurance
programs;
a)
report
to
the
IJC
at
least
annually
the
findings
of
surveillance
and
monitoring
programs
on the
Great
Lakes
and
provide
complete
details
of
sample
collection,
handling
and
analysis;
and
b)
meet
annually
to
discuss
the
significance of the
data
forthcoming
from
surveillance
and
monitoring
programs
and
to
propose
changes
in future
programs
as
deemed
scientifically
appropriate.
evaluate
their
surveillance
and
monitoring
programs
that
provide
data
pertaining
to
public
health,
in
terms
of
the
specific
requirements
listed
in
the
proceedings
of
the
Roundtable
and
alter
their
programs
as required.
Surveillance
and
Monitoring
of
Fish
and
Water
for
Organic
and
Inorganic
Chemicals:
It
is
recommended
that
the
jurisdictions
of
the
Great
Lakes
Basin:
5.
consider
immediately
surveillance
for
those
chemicals
identified
by
the
Committee
on
the
Assessment
of
Human
Health
Effects
in
Table
7.3
of
its
1982 Report
but
not
to
the
exclusion
of
those
listed
in
Table
7.5 of the 1982 Report;
address
the
issue
of
the
human
health
impact
of
chemicals
in
drinking
water;
a)
conduct
compliance
monitoring
programs
of
commercial
and
sport
fish
species
caught
for
consumption;
and
b)
augnent
surveillance
programs
for
the
identification
of
"new"
chemicals
and
the
determination
of
trends
of
"old"
chemicals;
continue
to
gather
data
on
the
fish
consumption
patterns
of
Great
Lakes Basin residents
in order that monitoring programs
can be
tailored
to
meet
consumption
patterns
and
health
risk
assessment
be
based on sound exposure figures; and
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resolve the "edible portion” issue by
a)
agreeing
on
a
"standard"
edible
portion;
or
b)
conducting research
on the relationships between different
protions
of
different
species
of
fish
such
that
data
from
different jurisdictions can be compared.
Surveillance
and
Monitoring
for
Microbiological
Contaminants
in
Water
Recommendations
It
is recommended
that
the
jurisdictions
of
the
Great
Lakes
Basin:
l0.
ll.
a) improve their reporting of waterborne disease outbreaks; and
b)
monitor,
more
frequently,
effluent
discharges
in
areas
where
waterborne disease outbreaks have occurred;
investigate
the
hazard
to
health
of bathing waters
by
a)
ensuring that current monitoring programs for bathing waters are
utilizing
the best
indicators
of contamination;
b) gathering data on those organisms identified as potentially
useful
indicators
of microbiological
contamination of water;
and
c) conducting research on the role between the microbiological
quality
of
bathing water
sediments
and
the
transmission
of
disease to bathers.
8.5
UPDATE
OF
TABLES
OF
GREAT
LAKES
CHEMICALS
PUBLISHED
IN THE
1981
ANNUAL
REPORT
 
l.
Those chemicals
listed in Table 7.3 of this
report (l982) be
considered for immediate inclusion in surveillance programs and that
certain groups of chemicals
listed in Table 7.5 be considered as
candidates for surveillance programs of
limited scope.
A new comprehensive list of chemical
substances
present and their
levels in the Great Lakes Basin ecosystem be prepared as soon as
possible and that it be coupled with up-to-date quantity and use data
for chemicals manufactured, used or released in the basin.
The Parties should again be urged to develop toxicity information
for
the chemicals in Table 7.5, identified as contaminants and/or in
widespread use in the Great Lakes Basin.
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 l.
SURVEILLANCE
AND MONITORING
FOR
ORGANIC
AND
INORGANIC
CONTAMINANTS
IN
FISH
l.l Considerations
Monitoring
programs
that
utilize
fish
tissue
(or
tissue
of
other
biota)
are
useful
primarily
for
the
detection
and
quantitation
of
lipid
soluble
organic
contaminants.
Lipophilic
contaminants
(e.g.
PCB,
mirex,
hexachlorobenzene,
DDE,
etc.)
often
accumulate
in
individual
fish;
concentrations
of
these
contaminants
in
predatory
species
further
up
the
food
chain
are
frequently
several
orders
of
magnitude
above
concentrations
in
water.
Alkylated
metal
species
(e.g.
methyl
mercury)
and
other
metal
complexes may also be present in fish
tissue;
however, metallic
ions rarely
accumulate
in
fish
tissue
to
high
levels
and
are
more
readily
observed
in
water and sediment.
There
are
three
major
objectives
for
fish
surveillance
and
monitoring
programs that relate directly to public health concerns
and one for monitoring
programs:
0
surveillance
of
fish
species
to
identify
new
or
previously
unrecognized contaminants; and
o
surveillance
of fish
species
over
time
to
establish
temporal
trends
in tissue concentrations of well known contaminants.
o
surveillance of short-lived,
local
fish species to identify
point-sources of contamination
o
compliance monitoring of commercial and sport fish to determine
whether or not fish residue levels exceed established guidelines;
For example,
whole
fish
analyses
provide
data
on
the
levels
of
numerous
toxic substances in the aquatic ecosystem and the levels are frequently 25% to
60%
higher
than
those
found
in
the
edible
portions
of fish.
Thus,
the
data
derived from whole fish are more frequently used for detecting trends
in
contaminant
levels
and
new
contaminants
and
data
from
edible
portion
analyses
are used for compliance purposes.
These objectives dictate the type of fish chosen, the number and portion
analysed, the time, location and frequency of sampling and the analyses
carried out.
 
The following section provides
details of program elements that must be
included if data arising from these programs are to be used for health hazard
evaluation.
l.2 Specific Requirements
 
l.2.l Fish Species Sampled
0
Compliance monitoring programs must select fish that are consumed by
the public. It is not necessary to analyse every sport and
commercial species from every location; however, the more commonly
caught species must be analysed.
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Surveillance for new, previously unrecognized contaminantsor th
determination of trends requires the selection of long-lived top
predators ( e.g., lake trout, coho salmon) and forage species (e.g.,
rainbow smelt, chub). Species selected should represent whole lake
conditions, i.e. they should be integrators of contaminants found
over a wide area.
Development of the use of nearshore species (e.g., spottail shiner)
capable of accumulating contaminants found in local areas (e.g., near
municipal water intake facilities) is encouraged.
l.2.2 Size Class and Sample Size
0
Compliance monitoring should provide data on a minimum of three (3)
size classes per species whenever possible. The size classes must be
representative of the usual range of sizes of that species caught for
consumption.
Selection of size classes that could be utilized by all Jurisdictions
would greatly improve comparability of data.
The large size classes of fish available should be utilized for the
identification of new contaminants in top predators. For example,
the use of 4 + year old lake trout is recommended.
Current levels of contaminants in the Great Lakes and within species
variation indicate that sample size should not be less than 20
individuals of any one size class from any single location. A 20-
fish sample is capable of detecting a l0—20% change in most
contaminant levels in a species from one year to the next (GLISP).
Pools or composites of fish are acceptable when individuals of the
species are small (e.g. smelt, chub, shiner) or extraction of large
amounts of contaminants is required.
l.2.3 Location, Time and Frequency of Sampling
0
  
Sampling for compliance must take place where fish are caught for
consumption by the public, i.e., major sport fishing areas and
commercial fishery operations.
 
Sampling for compliance must also take place when fish are caught for
consumption by the public. Ideal sampling schedules should coincide
with peak catch periods for the various speciesconsumed.
Frequency of sampling for compliance is dependent on the number of
peak catch periods per species.
If variations in contaminant levels
within a species are minor between peak catch periods then sampling
of fish during all time perioos is unnecessary.
Localized areas known to contain or suspected to contain contaminants
at levels of concern to health should be surveyed more frequently
using appropriate nearshore and whole lake species.
_
.
I
_
l
 
Location, time and frequency of sampling of fish species for "old"
contaminant surveillance should be coordinated among the
jurisdictions to minimize duplication of effort and to enhance
comparability of data.
.2.4 Analytical Considerations
Compliance monitoring programs must analyze "edibleportions" of fish
if they are to address health concerns. Definition of "edible
portion" has become a contentious issue within and between analytical
groups and jurisdictions and concurrence on a "standard edible
portion“ or the development of appropriate conversion factors is
urgently required to enhance comparability of data and consistency in
health hazard assessments.
Methods of analysis need not always be standardized, but rigorous
intra— and interlaboratory comparisons via a sample check program are
essential to retain public confidence in analytical capability and
ensure the validity of analysis results. Participation in existing
and future quality assurance programs is strongly recommended.
.2.5 Data Handling
Improved reporting of data is required to optimize its use. Emphasis
must be placed on the reporting of "new" contaminants and trends in
levels of "old" contaminants for health officials to revise or
conduct preliminary assessments, to set guidelines and to recommend
changes in monitoring and surveillance programs. Summary reports of
surveillance and monitoring activities should be provided to the IJC
each year and should include details of sample collection, processing
and analysis.
A central registry of data for contaminants in fish in the Great
Lakes would be useful for all jurisdictions. Currently there are
several computerized data bases in the jurisdictions that handle fish
contaminant data, e.g., OFIS (Ontario Fish Information System) in
Ontario and STORET in several states. A data system should be
capable of providing rapid retrieval of information.
.2.6 Other Considerations
It is essential to have information on the amounts (meal size and
freq
uenc
y)
of v
ario
us
fish
spec
ies
cons
umed
by r
esid
ents
of t
he G
reat
Lakes Basin (males and females), the peak consumption periods and the
pre
fer
enc
es
of
spe
cia
l
gro
ups
, i
.e.
,
eth
nic
, r
eli
gio
us,
socio-economic, native subpopulations, for certain species.
App
lic
ati
on
of
thi
s k
now
led
ge
to
the
sel
ect
ion
of
spe
cie
s f
or
surveillance and monitoring and to the calculation of average intakes
of
a v
ari
ety
of
con
tam
ina
nts
, w
ill
gre
atl
y e
nha
nce
the
rel
eva
nce
of
surveillance and monitoring programs to public health.
Tis
sue
ban
kin
g i
s o
f v
alu
e f
or
ret
ros
pec
tiv
e
ana
lys
es
of
con
tam
ina
nt
leve
ls
(and
past
huma
n ex
posu
re)
and
effo
rts
to d
evel
op f
ish
tiss
ue
ba
nk
s
sh
ou
ld
co
nt
in
ue
.
Sp
ec
ia
l
at
te
nt
io
n
sh
ou
ld
be
pa
id
to
th
e
storage conditions and their adequacy.
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2. SURVEILLANCE AND MONITORING FOR ORGANIC AND INORGANIC CONTAMINANTS IN WATER
2.l Considerations
In this century, the justification for the chlorination of water supplies
has been the perceived success in controlling microbiological pathogens.
Waterborne disease control is now taken for granted in most areas of North
America, hence the public's concerns have shifted and now focus on the
chemical quality of drinking water, i.e., the presence of environmental
contaminants (natural and anthropogenic) and use of water treatment chemicals
(e.g. chlorine, pH adjusters, alum, etc.) and of elective water additives
(e.g. fluorides). The implementation of existing and proposed drinking water
guidelines does not imply the production of a drinking water of standard
composition, i.e., water with identical pH, hardness, taste, colour,
turbidity, odour and chemical content; rather, it promotes the production of
water with individual measured parameters that do not exceed acceptable levels.
The measurement of organic and inorganic chemicals in water is an
important monitoring tool for identifying exposure to humans. Since the
measurenent of exposure to chemicals consumed in fish is carried out directly
on fish tissues, the main requirements for surveillance and monitoring for
chemicals in water are in the raw and finished drinking waters. The impact of
recreational exposures to chemicals in raw water is considered relatively
minor and will not be considered further.
Analyses of raw and finished drinking waters are carried out on a routine
and special-case basis by the responsible jurisdictions as required by current
drinking water guidelines and regulations in the United States and Canada.
Limits for several organic chemicals have been established and are generally
met in current water supplies. Unfortunately, the results of most compliance
monitoring programs of finished water are reported as either mean values
(without data on sample size, sampling location or time the standard deviation
or standard error) or they are reported as percent of samples meeting the
drinking water guidelines. Thus meaningful calculations of exposure are
almost impossible. The Province of Ontario is addressing this problem by
developing a system to record all sampling data from water treatment
facilities. It is hoped that this central facility will be able to provide
data useful for exposure calculations.
Compliance monitoring for known environmental chemicals in every municipal
water supply is expensive and time consuming. Currently one analysis per year
per site is common and practical.
Ideally, compliance monitoring programs
should adjust to allow for less frequent sampling of non-detectable
contaminants and increase the sampling frequency for those chemicals found at
unacceptably high levels.
When chemicals for which no guidelines have been established are
determined in appreciable quantities in water or are found in fish tissue
(indicating their presence in water) it is important that the jurisdictions be
able to conduct an assessment of the potential health risks and if indicated,
take appropriate action to reduce human exposure.
To conduct such an
evaluation the jurisdictions must have data on the levels and distribution of
the contaminant(s) in raw and finished water and data on the consumption
patterns (quantity, sources) of the exposed population. Often, sampling
frequency will need to be increased on a contingency basis to meet special
requirements for data.
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o
The
development
and
testing
of methodologies
that
detect
and
measure
levels of waterborne contaminants more
accurately and efficiently
should be encouraged.
2.2.5 Data Handling
0
Monitoring data should
appear as mean values per time perioa and
state
sample size, volume,
standard deviation
and standard error.
0
Compliance
monitoring
data
and
surveillance
data
pertaining
to
trends
in
"old"
contaminant
levels
and
to
"new"
chemicals
in
raw
and
finished
water
should
be
reported
to
a central
data
collection
agency.
Annual reports should be made available to the jurisdictions
and to the IJC.
N
.2.6 Other Considerations
0
Private
water
supplies
may have
low
pH
as
a result
of
acidified
rain
water and may cause extensive corrosion of some plumbing systems.
pH
is
routinely
adJUStQO
in
municipal
water
supplies,
hence,
these
water
supplies are unlikely to contribute to the corrosion of household
plumbing.
0
Testing
of
water
samples
for
mutagenicity
may
be
useful
for
the
assignment
of
priority
for
further
analysis;
however,
water
samples
that
show
mutagenic
activity
are
not
necessarily
harmful
to
health.
0
Although the contribution of waterborne chemicals
(including those
added
or
formed
during
water
treatment)
to
the
total
daily
intake
of
these
substances
via
food
and
air
is
likely
to
be
small,
there
is
a
need
to
examine
the
overall
long-term
effects
on
human
health
of
exposure
to
these
chemicals
in
water.
This
requirement
by
no
means
alters
the
important
need
to
disinfect
drinking
water
supplies.
3.
SURVEILLANCE
AND
MONITORING
FOR
MICROBIOLOGICAL
CONTAMINANTS
IN
WATER
3.l Considerations
Prior
to
the
initiation
of
disinfection
practices,
contamination
of
water
by
pathogenic
micro-organisms
posed
a
major
threat
to
human
health.
Conscientious
effort
and
innovation
have
reduced
the
incidence
of
serious,
wide-spread
waterborne
disease
outbreaks
in
North
America
dramatically.
Waters
(and
sediments)
may
be
classified
into
three
groups
on
the
basis
of
the
magnitude
of
the
impact
they
are
likely
to
have
on
human
health.
Group
1.
Finished
and
raw
drinking
waters
and
bathing
waters.
Drinking
water
has
the
greatest
potential
to
impact
on
health
because
it
is
ingested
in
large
quantity.
Bathing
waters.
Bathing
water
is
also
ingested
and
provides
extensive
opportunity
for
dermal
contact
by
microorganisms.
Surveillance
programs
designed
to
assess
the
impact
on
health
of
bathing
waters
must
examine
both
undisturbed
water
and
bathing
water
with
bathers
present.
These
two
approaches
allow
assessment
of
the
background
level
of
contamination
entering
or
present
in
the
bathing
area
and
the
contribution
of
the
bathers
themselves
to
the microbial
load
in
the
water.
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 Group
II.
Discharges
to
lake
waters.
Sewage
and
packing
plant
effluents
 
contribute
to
the
total
load
of
microorganisms
and
usually
contain
organisms
which
can
produce
disease
in
humans,
but
are
less
likely
to
be
in
a
direct
contact
with
man.
Bathing
water
sediments.
There
is
currently
little
information
on
the
part
played
by
bathing
water
sediments
in
the
transmission
of
waterborne
disease
and
the
lack
of
standardized
sampling
and
analytical
methodology
makes
interpretation
of
existing
data
difficult.
Specific
research
that
addresses
the
microbiological
characteristics
of
bathing
water
sediments
is
required
prior
to
further
assessment
of
the
health
hazard
posed
by
this
media.
Group
III.
Open
lake
waters.
These
waters
have
the
least
impact
on
human
health
because
human
exposure
to
them
is
limited.
3.2 Specific Requirements
3.2.l Parameters
The
parameters
for
which
measurements
are
required
in
the
surveillance
and
monitoring
of
microbiological
contaminants
fall
into
three
groups:
-
Parameters
that
are
monitored
on
a
routine
basis
(include
organisms
which
are
used
as
indicators
of
the
presence
of
human
and/or
animal
pollution
and
therefore,
the
presence
of
human
pathogens);
-
Parameters
that
have
the
potential
to
be
useful
but
for
which,
currently,
only
a
limited
data
base
exists.
Insufficient
information
is
available
as
to
the
utility
of
some
of
these
parameters
for
health
assessment,
however,
their
inclusion
into
monitoring
programs
on
a
trial
basis
should
be
encouraged;
and
-
Parameters
that
measure
waterborne
pathogens
(includes
bacteria,
viruses and parasites).
The
analytical
requirements
for
each
of
these
three
parameter
groups
have
been
tabulated
using
the
classification
of
water
into
Groups
I,
II,
and
III.
0
Table
l
lists
the
water
group
and
the
common
indicators
of
water
quality which
are
currently
used.
Each
indicator
organism
is
assigned
a
numerical
ranking
to
denote
its
utility
for
a
given
water
type,
using
I for
essential
parameters,
2
for
very
useful
parameters
and 3 for useful parameters.
0
Table
2
lists
those
organisms
that
may
be
of
potential
use
for
health
risk assessment in the specific water
groups shown.
However,
sampling
and
isolation
methods
for
these
organisms
have
not
been
refined or standardized and the interpretation of their presence in
waters
in
terns
of
human
health
impact
remains
equivocal.
It
is
not
necessary to investigate open waters for these parameters.
The
collection
of more
data
on
the
occurrence
of these
microorganisms
in
these specific areas will enable their ultimate role in human health
assessment to be determined.
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TABLE 1. ROUTINE PARAMETERS USED AS INDICATORS
OF MICROBIOLOGICAL CONTAMINATION OF WATER
CoTiforms
Escherichia Otherb
EnterococcusC Pseudomonas
Group
TotaT
Feca]a
coli
CoTiforms
aeruginosa
I Drinking Water
Finished 1 I l — 3
Raw - l 1 3 3 -
Bathing Water —
1
1
2
2
2
II Discharges
-
l
1
1
3
—
Bathing
-
1
1
—
1
3
Sediments
III Open Water 1 3 - — - _
a Confirmatory test if totaI C01iform 1eve1 is high.
Klebsiella, Aeromonas, Citrobacter, Enterobacter
C Standard Methods for the Examination of Water and Nastewater, 14th ed.,
APHA, Washington, D.C., 1976
N.B.
Parameters:
l-essentia];
2-very useful; and 3-usefu1
TABLE 2.
POTENTIAL INDICATORS 0F MICROBIOLOGICAL CONTAMINATION OF WATER
 
ORGANISM
Staphylococcus
Clostridium
Candida
Group
aureus
perfringens
albicans
Coliphages
Bifidobacteria
Drinking Water
Finished
—
X
—
X
-
Raw
—
X
-
-
X
Bathing Water
X
-
X
-
X
Discharges
-
—
-
—
X
Bathing
X
X
-
-
—
Sediments
X-recommendation
for
monitoring
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Where an epidemiological study of a specific waterborne outbreak is
undertaken, or where a defined population will be studied for
evidence of waterborne disease, it may be necessary to undertake
surveillance of one or more of the following waterborne pathogens:
Aeromonas hydrophila - ampylobacter species — Enteric viruses
 
- Giardia lamblia — egionella species
- Schistosoma species — Salmonella species
- Pathogenic amoeba - Shigella species
- Yersinia enterocolitica
 
The isolation and sampling methodologies for these organisms in water
is not yet fully developed and in certain cases, the specific types
that are virulent for humans cannot be identified. For these
reasons, interpretation of any isolations must be made with extreme
caution.
3.2.2 Location and Frequency
Monitoring of finished drinking water must be carried out to ensure
the safety of drinking water and to indicate that efficient treatment
procedures have been employed and that the integrity of the
distribution system has been maintained. Minimum sampling regimes and
methoos are specified by the various jurisdictions and these are
considered to be adequate at present. However, data on the levels of
residual chlorine at the time of sampling would be very useful.
Rou
tin
e m
oni
tor
ing
of
raw
dri
nki
ng
wat
er
sho
uld
be
car
rie
d o
ut
to
ensure that treatment methoas will be adequate to prevent finished
wat
er
con
tam
ina
tio
n.
The
sam
pli
ng
fre
que
ncy
and
met
hod
is
spe
cif
ied
by the Jurisdictions; frequency will depend generally upon the
mic
rob
iol
ogi
cal
his
tor
y,
the
sea
son
of
the
yea
r,
the
pot
ent
ial
sources of pollution and the population at risk.
Min
imu
m s
amp
lin
g f
req
uen
cie
s f
or
rec
rea
tio
nal
wat
ers
are
det
erm
ine
d
by
the
Jur
isd
ict
ion
s a
nd
in
gen
era
l a
deq
uat
ely
add
res
s h
eal
th
ris
k
ass
ess
men
t f
or
the
dur
ati
on
of
the
rec
rea
tio
nal
sea
son
.
It
sho
uld
be
rec
ogn
ize
d t
hat
a s
ani
tar
y s
urv
ey
of
an
are
a i
s a
n e
sse
nti
al
com
pon
ent
of
any
ass
ess
men
t o
f t
he
hea
lth
haz
ard
to
bat
her
s.
Sam
ple
s
of
bat
hin
g b
eac
h w
ate
r s
hou
ld
be
col
lec
ted
at
rep
res
ent
ati
ve
are
as
at
eac
h b
eac
h a
nd
ups
tre
am
of
are
as
sub
jec
t t
o i
nfl
uen
ce
fro
m p
oin
t
sou
rce
dis
cha
rge
s.
Mul
tip
le
ind
ivi
dua
l s
amp
les
are
pre
fer
red
, b
ut
com
pos
ite
sam
ple
s
may
be
use
ful
in
scr
een
ing
pro
gra
ms.
Rou
tin
e
sam
pli
ng
sho
uld
be
at
a d
ept
h o
f l
5-3
0 c
m b
elo
w t
he
sur
fac
e o
f w
ate
r
tha
t i
s l
-l.
5 m
dee
p.
In
int
ens
ive
sam
pli
ng,
wat
er
sho
uld
be
col
lec
ted
at
var
iou
s d
ept
hs
in
the
wat
er
col
umn
, t
hro
ugh
out
the
def
ine
d
bat
hin
g
are
a.
To
bet
ter
def
ine
bat
her
con
tri
but
ion
,
sam
ple
s
fro
m t
he
sur
fac
e f
ilm
of
the
wat
er
may
be
use
ful
.
(Th
is
fil
m n
ot
on
ly
wo
ul
d
te
nd
to
co
nc
en
tr
at
e
or
ga
ni
sm
s
sh
ed
wi
th
the
bo
dy
Oi
ls
and
sec
ret
ion
s,
but
is
the
are
a
of
wat
er
mos
t
usu
all
y
in
con
tac
t
wit
h
the
eye
s,
ea
rs
, n
os
e
and
mo
ut
h
of
the
ba
th
er
s)
.
Th
e
co
nd
it
io
ns
un
de
r
whi
ch
sam
ple
s
are
col
lec
ted
sho
uld
be
rec
ord
ed,
wit
h
suc
h
det
ail
s
as
the
est
ima
ted
bat
her
loa
d
at
the
tim
e,
so
tha
t
app
rop
ria
te
interpretation of the results can be made.
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 Point
sources
of
potential
microbial
pollution
that
are
likely
to
impact
on
human
health,
by
contamination
of
raw
drinking
waters
or
bathing
waters,
etc.
should
be
monitored
in
order
to
identify
types
of
microbial
contaminants
and
their
numbers,
as
well
as
to
determine
compliance
with
effluent
discharge
objectives.
Monitoring
of
effluents
for
microorganisms
is
important
in
the
determination
of
the
degree
of
pathogen
elimination
achieved
by
treatment
processes;
however,
not
all
of
the
jurisdictions
in
the
Great
Lakes
Basin
have
set bacteriological
limits for their sewage and industrial
effluents
and
monitoring
of
this
type
is
sporadic.
3.2.3
Analytical
Considerations
Sampling
and
analytical
procedures
for
identification
and
quantitation
of
microbiological
parameters
should
be
as
standardized
as
possible
between
the
Jurisdictions.
3.2.4 Data Handling
The
methoo
of
sample
collection
and
analysis
should
be
provided
with
all data.
The
poor
quality
of
waterborne
disease
reporting
is
a
problem
common
to
all
the
jurisdictions
and
affects
assessments
of
the
health
impact
of
water
used
for
drinking
and
recreation.
With
the
possible
exception
of
Pennsylvania,
investigation
of
suspected
waterborne
outbreaks
of
disease
is
not
vigorously
pursued
and
reporting
tends
to
be
inaccurate
and
fragmented
among
the
various
agencies
concerned.
More
frequent
and
more
complete
reporting
of
waterborne
disease
outbreaks
should
be
implemented.
An
annual
summary
report
to
the
IJC
is recommended.
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 APPENDIX 2
A. SPECIFIC CHANGES TO TABLES 4 AND 5 OF THE 1981 ANNUAL REPORT
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 Table 7.4, has been prepared using Table 4, 1981, as its base.
listed in 1981 and do not appear in 1982 are listed as "deletions".
Specific changes made to Table 4.
 
Chemicals that were
Chemicals that did
not appear on the 1981 table but have been added this year are listed as "additions".
Chemicals have been added or deleted for four basic reasons:
the chemical was listed
twice in Table 4; the chemical has been re-evaluated and moved to Table 7.4; the
chemical was accidentally omitted or mistakenly included in 1981; or the chemical has
been renamed (the old name deleted and the new name added).
The addition to Table 7.4
of isomeric forms of any one chemical has not been relisted below.
ADDITIONS
RATIONALE
DELETIONS
Acetophenone Unlikely to pose a health hazard,
rapidly degrades in the environment.
Appeared in Table 5, 1981.
Carbofuran Carbamate insecticide, rapidly degraded
N,N-Dimethylaniline
Docosanoic acid
l-Dodecanol
Eicosanoic acid
Heptene
9- Octadecenoic
acid, methylester
Phenol
in the environment and unlikely to pose
a long-term health hazard. Omission from
Table 4, 1981, was an error.
Mistakenly listed in parentheses after
Dimethyl adipate in Table 4, 1981.
Unlikely to pose a health hazard, similar
properties to other short chain acids.
Appeared in Table 5, 1981, as Arachidic
acid.
Unlikely to pose a health hazard, similar
properties to other short chain saturated
alcohols. Appeared in Table 5 1981.
Unlikely to pose a health hazard, similar
properties to other short chain acids.
Appeared in Table 5, 1981, as Behenic acid.
Unlikely to pose a health hazard, similar
properties to other short chain alkenes.
Appeared in Table 5, 1981.
Unlikely to pose a health hazard, similar
properties to other short chain esters.
Appeared in Table 5, 1982, as Methyl
linoelaidate (incorrectly named)
Rapidly degraded, few long term effects.
Water quality objective based on taste.
Omission from Table 4, 1981, was an error.
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 SPECIFIC
CHANGES
TO
TABLE
4
(CON'T)
ADDITIONS
RATIONALE
DELETIONS
Tetracosanoic
Unlikely
to
pose
a health
hazard,
similar
acid
properties
to
other
short
chain
acids.
Appeared
in
Table
5,
1981,
as
Lignoceric
acid.
Vanadium
Unlikely
to
pose
a
health
hazard
after
long-
term, low level exposure. See Summary
Evaluation
in
1981
Report.
Appearance
in
Table 5, 1981, in error.
Already
appears
as
Tetradecanoic
acid
in
Myristic
acid
Table 4, 1981.
Already
appears
as
Hexadecanoic
acid
in
Palmitic
acid
Table 4, 1981.
A
class
of
compounds
and
not
an
individual
Terpene
chemical with a CAS number
3enzo(k)fluoranthene
Renamed
Benzo(k)
fluoranthrene
Z-Butanone
Renamed
Methyl
ethyl
ketone
2-Buten-l—ol
Renamed
But-Z—en-l-ol
Dibenzo
(def,mno)
Renamed
Dibenz
(def,mno)
chrysene
chrysene
Oicamba
Renamed
3,6—Dichloro-2—
methoxy benzoic
acid
Dichlorobromofluoro
Renamed
Fluorodichloro-
methane
bromomethane
1,2-Dihydro-6-
Renamed
Methyl
dihydro—
Methylnaphthalene
naphthalene
9,10-Dihydroxy
Renamed
Methyl
dihydroxy
octadecanoic
acid,
sterate
methyl ester
Dodecanoic
acid,
Renamed
Methyl
laurate
methyl ester
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SPECIFIC CHANGES TO TABLE 4
(CON'T.)
 
ADDITIONS RATIONALE DELETIONS
Eicosanoic acid, Renamed Methyl
methyl ester arachidate
2—Ethylhexanoic acid Renamed Methyl ethyl
methyl ester hexanoate
Fluoranthene Renamed Fluoranthrene
9-Hexadecenoic acid Renamed Palmitoleic acid
Hexanedioic acid Renamed Dihexyl adipate
dihexyl ester
Hexanedioic acid, Renamed Dimethyl adipate
dimethyl ester
Hexadecanoic acid, Renamed Ethyl palmitate
ethyl ester
Hexadecanoic acid, Renamed Methyl palmitate
methyl ester
Methacrylic acid, Renamed Methyl
methyl ester methacrylate
4—Methyl—2- Renamed Methyl isobutyl
pentanone ketone
9,12—0ctadecadienoic Renamed Linoleic acid
acid
9—0ctadecenoic acid (cis) Renamed Oleic acid
Octadecanoic acid, Renamed Methyl stearate
methyl ester
9,12,15-0ctadeca- Renamed Methyl
trienoic acid, linolenate
methyl ester
Phthalic acid, butyl Renamed Butyl phthalyl
ester, ester with butylglycolate
butylglycolate
Phthalic acid, Renamed Dibutylphthalate
dibutyl ester
Tetradecanoic acid, Renamed Methyl myristate
methyl ester
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 Specific Changes to Table 5.
 
Table 7.5 has been prepared using Table 5, 1981, as its base.
changes involve deletions from the old table for the following reasons: the chemical
was re—evaluated and assigned to another table; the chemical was listed twice in
Tables 2 through 5, 1981.
The majority of
Although a large number of chemicals have been renamed,
the addition to Table 7.5 of isomeric forms of any one chemical has not been relisted
below.
ADDITIONS
RATIONALE
Incorrect name, already appears in Table
7.5 as Dehydroabietic acid.
Unlikely to pose a health hazard, moved to
Table 7.4.
Unlikely to pose a health hazard, moved to
Table 7.4 as Eicosanoic acid.
Moved to Table 7.4, see Summary Evaluation
Unlikely to pose a health hazard, moved to
Table 7.4 as Docosanoic acid.
Moved to Table 7.3, see Summary Evaluation.
Moved to Table 7.2, see Summary Evaluation
A trihalomethane, moved to Table 7.2.
A trihalomethane, moved to Table 7.2.
A trihalomethane, moved to Table 7.2.
Moved to Table 7.3, see Summary Evaluation.
Covered under Polychlorinated biphenyl
in Table 7.2.
Double listed in Table 2 and 5. Correctly
listed in Table 7.2.
Already appeared in Table 7.5 as chlorodi-
bromomethane, moved to Table 7.4 as
chlorodibromomethane
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DELETIONS
6,8,11,13—
Abietate-triene—
l8—oic acid
Acetophenone
Arachidic acid
Atrazine
Behenic acid
Benzo(b)
fluoranthene
Benzolj)
fluoranthene
Bromodichloro-
methane
Bromoform
Chlorodibromo—
methane
Cresol
Decachloro—
biphenyl
Diazinon
Dibromochloro-
methane
SPECIFIC CHANGES TO TABLE 5 (CON'T.)
  
ADDITIONS RATIONALE DELETIONS
Not a specific compound with a CAS number. Dichlorocyclo—
diene resin
acids
Moved to Table 7.3, see Summary Evaluation
Appears already in Table 7.4 as 3,4-
Dimethoxyacetophenone.
Unlikely to pose a health hazard, moved
to Table 7.4.
Moved to Table 7.3, see Summary Evaluation.
Double listed in Tables 5 and 2.
Currently listed in Table 7.2.
Double listed in Tables 5 and 2.
Currently listed in Table 7.2.
Unlikely to pose a health hazard,
moved to Table 7.4.
A trihalomethane, moved to Table 7.2.
Appears already in Table 7.4 as Dodecanoic
acid.
Unlikely to pose a health hazard, moved
to Table 7.4 as Tetracosanoic acid.
Appears already in Table 7.4 as Guaiacol
Appears already in Table 7.4 as Guaiacol.
Appears already in Table 7.4 as
Methylanthracene
Appears already in Table 7.4, renamed
1,2-Dihydro—6-methyl naphthalene
Appeared already in Table 4 as Methyl-
dihydroxy— stearate and has been renamed
9,lO-Dihydroxy-octadecanoic acid, methyl
ester in Table 7.4
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1,2-Dichloroe-
thylene
Dimethoxyaceto—
phenone
l-Dodecanol
Endosulfan
Heptachlor
Heptachlor
epoxide
Heptene
Iododichloro—
methane
Lauric acid
Lignoceric acid
Methoxyphenol
o—Methoxyphenol
Methylanthracene
(1-,2- and 9—)
6-Methyl-1,2-di-
hydro
naphthalene
Methyl—9,10-
dihydroxy
ester
 
 SPECIFIC CHANGES TO TABLE 5 (CON'T.)
ADDITIONS RATIONALE DELETIONS
Appears already in Table 7.4 as Methylene
Dichloromethane. chloride.
Appears in Table 7.4. lO—Methyl—
eicosane
Appears already in Table 7.4 and has been
renamed Z-ethylhexanoic acid, methyl ester
Appears already in Table 7.5 as Methyl—7-
oxodehydroabietate
Unlikely to pose a health hazard, moved
to Table 7.4 as 9—0ctadecenoic acid, methyl
ester (trans) (Methyl elaidate).
Appears already in Table 5 as Cresol, moved
to Table 7.3.
Appears already in Table 7.5 as
Pentachloroanisole
Appears already in Table 7.5 as
Tetrachloroanisole
Appears already in Table 7.5 as
Trichloroanisole
Not a specific compound with a CAS
number
Included under chlorinated naphthalene
in Table 7.3.
Appears already in Table 4.
Not a specific compound with a CAS
number
Not a specific compound with a CAS
number.
Appears already in Table 7.5 as 3,4,5-
Trichloroveratrole
Appears already in Table 7.4 as Pinene
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Methylethyl—Z—
hexanoate
Methyl-7—ketode-
hydroabietate
Methyl
linoelaidate
2-Methyl phenol
Methylpentachloro-
phenyl ether
Methyltetrachloro—
phenyl ether
Methyltrichloro—
phenyl ether
Monochlorocyclo-
diene resin acids
Octachloro—
naphthalene
Pinene, a- and B-
Tetrachlorocyclo-
diene resin acids
Trichlorocyclo-
diene resin acids
Trichlorodimeth-
oxy—phenol
Trimethylbicyclo-
3,11-heptene
SPECIFIC CHANGES TO TABLE 5
(CON'T.)
  
ADDITIONS RATIONALE DELETIONS
Uniikeiy to pose a heaith hazard, moved Vanadium
to Tabie 7.4.
Abietic acid, Renamed Methyi abietate
methyi ester
6—Benzothiazoioi Renamed Hydroxy benzo
thiazoie
Buty]benzene(n,—sec-, Renamed Aikyi benzene
tert-) and Isopropyi
methyibenzene
2—Chioro-a-(4- Renamed Diphenyiacetaide-
chiorophenyi) hyde, dichioro
benzeneacetaidehyde derivative
4-Chioro-1,2- Renamed Chioroveratroie
dimethoxybenzene
Chiorophenoi Renamed Monochiorophenoi
(2-,3-,4—)
2-(4-Ch10rophenoxy) Renamed Methy1-2(4-ch10ro
butanoic acid, phenoxy)
methyl ester butanoate
2-Ch10ro-a-pheny1— Renamed Diphenyiacetaide-
benzeneacetaidehyde hyde, monochioro
derivative
2-Ch10ro—1-pheny1-l- Renamed Chioropropio-
prop
anon
e
phen
one
DMPA Renamed Zytron
Dichioroanisoie Renamed Methy] dichloro-
phenyi ether
1,2-Dich10ro—4,5— Renamed Dichioroveratroie
dimethoxybenzene
Dichioromethoxy phenoi Renamed Dichioroguaiaco]
Dehydroabietic acid, Renamed Methy1
methy
i es
ter
dehyd
roabi
etate
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SPECIFIC CHANGES TO TABLE 5
(CON'T.)
 
ADDITIONS RATIONALE DELETIONS
Ethion
Renamed
N—(3,4-dichloro—
phenyl)—N,N—
diethylurea
B—Hexachlorocyclo—
Renamed
B-Benzene hexa-
hexane chloride
Isopimaric acid,
Renamed
Methyl
methyl ester
isopimarate
6—Methyl—2-benzo—
Renamed
Methyl thiobenzo—
thiazolethiol
thiazole
2—Methoxy-1—(4-
Renamed
Acetovanillone
methoxyphenyl)
ethanone
Neoabietic acid,
Renamed
Methyl
methyl ester
neoabietate
7-0xodehydro—
Renamed
methyl-7-oxode-
abietic acid,
hydroabietate
methyl ester
a-Phenylbenzene-
Renamed
Diphenylacetalde-
acetaldehyde hyde
Phthalic acid, butyl-
Renamed
Butylbenzyl
benzyl ester phthalate
Phthalic acid,
Renamed
Diethyl
diethyl ester
phthlate
Phthalic acid,
Renamed
Dimethyl
dimethyl ester
phthalate
Phthalic acid,
Renamed
Dioctyl
dioctyl ester
phthalate
Pimaric acid,
Renamed
Methyl pimarate
methyl ester
Sandaracopimaric
Renamed
Methyl sandaraco-
acid, methyl ester
pimarate
Stilbene oxide
Renamed
Trans-stilbene
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oxide
 
 SPECIFIC CHANGES TO TABLE 5 (CON'T.)
ADDI
TION
S
RATI
ONAL
E
DELE
TION
S
Tetr
ach1
0rom
etho
xy—
Rena
med
Tetr
ach1
oro-
phen
ol
guai
acol
1,2,
5,6-
Tetr
athi
o1-
Rena
med
Tetr
athi
o—
hexa
ne
hexa
ne
1,2,
3—Tr
1ch1
oro—
4,5-
Rena
med
3,4,
5-Tr
ichl
oro-
dime
thox
yben
zene
vera
tro1
e
Tri
ch1
oro
met
hox
y—
Ren
ame
d
Tri
ch1
oro
gua
iac
01
pheno]
1-(2,2',4'-Trich10ro[1,1'-Bipheny1]—4-y1)ethanone; and
2,2-Dich10ro—1—(2'-Ch1oro[1,1'-Bipheny1]—4-y1)ethanone
Renamed
Triethy1eneg1yco1- Renamed
ethy1 ether
1,3,5-Trithio1pentane Renamed
69
Diphenylacetal-
dehyde,trich10ro—
and dich1oro-
derivatives
2—(2-(2—ethoxy—
ethoxy) ethoxy)
ethano]
Trithiapentane
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Atrazine
(CAS
Reg.
No.
l9l2
249)
(Table:
7.4)
Exposure profile:
This
herbicide
has
been
detected
in
agricultural
watersheds
tributary
to
Lake
Erie
(up
to
l0
pg/l)
and
in
Lake
Erie
sediments
(20
ng/g).
Significant
amounts
are
handled
in
the
Great
Lakes
Basin.
Toxicity profile:
Oral
L050:
l.75
to
3.08
g/kg
in
various
rodent
species
(l).
Carcinogenicity:
Mice
dosed
orally
with
2l.5
mg/kg/day
for
80
weeks
exhibited
a
hepatoma
incidence
of
5.6
percent
versus
4.24
percent
for
c
o
n
t
r
o
l
s
.
(
3
)
Chronic
Adverse
Effects:
Rats
fed
500
ppm
atrazine
in
the
diet
for
6
months
exhibited
a
retardation
in
growth
which
was
partially
due
to
reduced
food
intake.
Histological
examination
revealed
no
lesions
(l09).
CNS
Effects:
Rats
administered
oral
and
interperitoneal
LDso
levels
of
l,400
and
l25
mg/kg,
respectively,
showed
excitation
followed
by
depression
with
reduced
respiratory
rate,
motor
incoordination,
clonic
and
sometimes
tonic
spasms
and
hypothermia
(ll2).
Reproductive
Effects:
Subcutaneous
injection
of
800
mg/kg/day
on
days
3,
6
and
9
of
gestation
resulted
in
death
and
resorption
of
some
or
all
of
the
pups
in
each
rat
litter.
Dosages
as
high
as
200
mg/kg/day
dld
not
affect
the
number
of
pups
per
litter
nor
their
weight
at
weaning
(ll3).
Teratogenicity:
No
data
found.
Mutagenicity:
Mutagenic
in
some,
but
not
all,
tests
in
Drosophila
melanogaster
(llO).
Atrazine
was
not
mutagenic
in yeast
or
Aspergillus
sp with
or
without
addition
of activated
mouse
liver
microsomal
enzymes
(lll).
Permissible
Exposure
Limit:
Acceptable
da3ly
intake
is
calculated
to
be
0.0375
mg/kg/day (ll7). TLV is l0 mg/m (43).
Immediately Dangerous to Life or Health:
Probable lethal
dose in humans
0.5-59/kg or between l 02. and l pint for a 70 kg. person (74).
Existing
Environmental
Regulations:
None
known.
 
Recommendation:
Atrazine is used in moderate quantities in the Great Lakes
aSin.
Its acute and chronic toxicity for mammals is low.
Although
data on levels of atrazine in biota and media are few, there appears
to be very little in the environment.
Atrazine is unlikely to pose a
health hazard to residents of the Great Lakes Basin at this time.
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Benzo
(b
and
j)
fluoranthene
(CAS
Reg.
No.
206—99-2
(Table:
7.3)
and 205-82-3)
Exposure profile:
Both
Benzo(b)
and
Benzo(j)
fluoranthene
are
found
in
the
exhaust
of
gasoline engines and in cigarette smoke.
They have been detected
in
air,
water
and
soil.
Both
have
been
reported
in
food
at
mg/kg
levels
(63).
Toxicity profile:
Oral
L050:
No
oral
acute
toxicity
data
found.
The
minimal
toxic
dose
(TDLO)
for
mice
painted
with
B(b)F
is
40
mg/kg
and
3l2
mg/kg
(l)
with B(j)F.
Carcinogenicity:
Benzo(b)
fluoranthene-
In
an
experiment
with
no
control
group,
mice
were
skin
painted
three
times
weekly with
0.5
percent
B(b)F
in
acetone.
After
8
months,
lOO
percent
had
papilloma's,
90
percent
carcinomas.
Treatment
with
a 0.l
percent
solution
caused
65
percent
of
the
mice
to
develop
papillomas
and
85
percent
carcinomas
after
l2
months.
Fourteen
months
of
treatment
with
a 0.0l
percent
solution
produced
papillomas
in
l0
percent
of
the
mice
(63).
B(b)F
has
not
been tested
in other species or by
other routes
(63).
Benzo(j)
fluoranthene-
95
percent
of
mice
painted
3
times
weekly
with
0.l
percent
or
0.5
percent
B(j)F
in
acetone
developed
carcinomas
after
7
to
9
months
of
treatment.
Papillomas
were
also
observed.
B(j)F
has
not
been
tested
in
other
species
or
by
other
routes
(63).
Chronic
Adverse
Effects:
No
data
found
other
than
carcinogenicity
results.
CNS
Effects:
No
data
found
but
unlikely
to
cause
CNS
effects.
Reproductive
Effects:
No
data
found.
Other
PAH's
like
benzo(e)
pyrene
cause
reproductive
anomalies
(55).
Teratogenicity:
No
data
found.
Benzo(e)
pyrene
is
a
suspect
teratogen
(l5).
Mutagenicity:
No
data
found
but
unlikely
to
be
highly
mutagenic.
Permissible
Exposure
Limit:
Not
established.
Immediately
Dangerous
to
Life
or
Health:
Not
established.
Existing
Environmental
Regulations:
The
WHO
has
recommended
a
maximum
of
0.2 pg total PAH/L in water.
Recommendation:
Benzofluoranthene
is
produced
from
a
wide
variety
of
combustion
sources
and
is
ubiquitously
distributed
and
results
from
a
wide
variety
of
combustion
sources.
Like
other
PAH‘s,
benzo(b)
and
benzo(j)
are
likely
to
be
skin
carcinogens.
Levels
of
PAH's
should
be
determined
in
water,
fish
and
air.
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Cresol
(o—,m-,p-)
(CAS
Reg.
No.
l3l9773)
(Tables:
7.l
and
7.3)
Exposure profile:
Large
amounts
of
cresols
(>
105
kg)
are
used
in
the
Great
Lakes
Basin
annually
by
the
chemical
industry.
No
information
on
levels
in
the
environment
was
available.
Toxicity profile:
Oral
LDso:
861-2000
mg/kg
in
various
rodent
species.
(l)
Carcinogenicity:
Twenty
two
dermal
applications
over
ll
weeks
of
cresol
isomers
(as
a
20
percent
solution
in
benzene)
mixed
with
DMBA
(in
acetone)
to
mouse
skin
resulted
in
a
relative
increase
in
the
numbers
of
mice
with
papillomas
compared
to
DMBA
treated
controls.
No
Carcinomas
were
observed.
Cresol
is
a
tumor
promotor
in
mice
(ll4).
It
has
not
been
tested
neat.
Chronic
Adverse
Effects:
Chronic
poisoning
from
oral
or
percutaneous
absorption
may
produce
digestive
distrubances
and
nervous
disorders,
vertigo,
mental
changes,
skin
eruptions,
jaundice,
oliguria
and
uremia. (67, ll8)
CNS
Effects:
Rabbits
exposed
dermally
to
any
of
the
three
isomers
in
doses
of
1
ml/kg
for
24
hrs.
exhibited
the
following
CNS
effects:
salivation,
lacrimation;
hypoactivity,
tremors,
convulsions,
sedation
and
death
(ll5).
Cresol—exposed
workers
developed
headache,
nausea
and
o
c
c
a
s
i
o
n
a
l
l
y
c
o
n
v
u
l
s
i
o
n
s
.
(
l
l
6
)
Reproductive
Effects:
No
data
found.
Teratogenicity:
No
data
found.
Mutagenicity: No data found.
Permissible
Exposure
Limit:
ACGIH
gives
a
TLV
value
of
5
ppm.
or
22
mg/m3
but
specifies
for
exposure
to
skin.
(43)
Immediately
Dangerous
to
Life
or
Health:
Lethal
dose
in
humans
has
been
estimated
to
be
50—500
mg/kg
(74)
and
lOg
(ll9).
Existing
Environmental
Regulations:
In
as
much
as
cresol
is
a
phenolic
compound,
there
is
a
Canadian
Drinking
Water
Guideline
(based
on
odour) for phenols of 2 pg/L.
Recommendation:
Large
amounts
of
cresols
are
used
in
the
Great
Lakes
Basin
ut
little
is
known
about
levels
in the
environment.
Cresol
is not
particularly
toxic
after
acute exposure,
however
it may
be
a tumor
promotor
after
skin
contact.
Surveillance
of
industrial
effluents
and
nearshore
water
is
recommended
to
determine
levels.
75
 Immediately Dangerous
to Life or Health:
For l,2—DCE,
4000 ppm (OSHA)
(42).
Existing
Environmental
Regulations:
None
found.
Recommendation:
Dichloroethylene is used in large quantities in the basin and
the
l,2-DCE
has
been
reported
in water.
Although
there
are few
chronic toxicology data, l,l-DCE has been identified as an animal
carcinogen.
Surveillance
for l,2-DEC is recommended to determine
levels in industrial effluents and water.
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Endosulfan
(CAS
Reg.
No.
2157l99)
(Tables:
7.l
&
7.3)
Exposure profile:
This
agricultural
p
e
s
t
i
c
i
d
e
is
found
in
the
wa
t
e
r
column
(0.002
to
0.25
ug/L,
form
predominant)
in
sediments
(up
to
l6.0
pg/g
dwt,
a
and
B
forms)
in
air
(up
to
l.0
ppt)
and
rainwater
(2.0
ppt,
B
form
predominant).
Usage
is
2.8
million
pounds
in
New
York
alone.
Use
is
by
licensed
a
p
p
l
i
c
a
t
i
o
n
(which
includes
farmers)
and
is
essentially
without
restrictions.
Typical
applications
are
in
potato
and
tomato
production.
The
compound
is
t
r
a
n
s
f
o
r
m
e
d
by
m
i
c
r
o
b
e
s
to
endosulfandiol,
but
probably
is
not
completely
mineralized.
Endosulfan
is
p
r
a
c
t
i
c
a
l
l
y
insoluble
in
water;
data
on
b
i
o
a
c
c
um
ul
a
t
i
o
n
were
not
available
from
ISHON.
Toxicity profile:
Oral
L050:
2mg/kg
in
cats
and
l8—ll8
mg/kg
in
rodents.
(l)
Carcinogenicity:
An
N
C
I
-
s
p
o
n
s
o
r
e
d
b
i
o
a
s
s
a
y
indicates
that
e
n
d
o
s
ul
f
a
n
is
not
an
animal
carcinogen
under
the
conditions
of
the
study
(3)
Chronic
Adverse
Effects:
When
rats
were
given
l00
ppm
of
endolsulfan
in
their
diet
for
2
years,
adverse
effects
included:
decreased
S
u
r
v
i
v
a
l
;
d
e
c
r
e
a
s
e
d
w
e
i
g
h
t
g
a
i
n
;
d
e
c
r
e
a
s
e
d
t
e
s
t
e
s
w
e
i
g
h
t
;
and
s
i
g
n
i
f
i
c
a
n
t
r
e
n
a
l
t
u
b
u
l
a
r
d
a
m
a
g
e
(22).
CNS
Effects:
Occupational
e
xp
o
s
ur
e
to
e
n
d
o
s
ul
f
a
n
dust
has
been
reported
to
cause
confusion
and
excitement
(4)
and
epileptiform
convulsions
(l2l).
R
e
p
r
o
d
u
c
t
i
v
e
E
f
f
e
c
t
s
:
A
t
h
r
e
e
-
g
e
n
e
r
a
t
i
o
n
r
e
p
r
o
d
u
c
t
i
o
n
s
t
u
d
y
s
h
o
w
e
d
n
o
e
f
f
e
c
t
on
the
reproduction
performance
and
survival
indices
of
rats
m
a
i
n
t
a
i
n
e
d
o
n
a
d
i
e
t
c
o
n
t
a
i
n
i
n
g
5
0
p
p
m
o
f
e
n
d
o
s
u
l
f
a
n
(
2
l
)
.
H
o
w
e
v
e
r
,
oral
dosages
of
5
m
g
/
k
g
/
d
a
y
and
greater
on
day
6-l4
of
gestation
r
e
s
u
l
t
e
d
in
i
n
c
r
e
a
s
e
d
m
o
r
t
a
l
i
t
y
o
f
rat
d
a
m
s
and
i
n
c
r
e
a
s
e
d
fetal
resorptions
and
skeletal
anomalies
(l07).
Degenerative
changes
in
s
e
m
e
n
i
f
e
r
o
u
s
t
u
b
u
l
e
s
and
a
s
i
g
n
i
f
i
c
a
n
t
d
e
c
r
e
a
s
e
in
t
e
s
t
i
c
u
l
a
r
w
e
i
g
h
t
were
o
b
s
e
r
ve
d
in
m
a
l
e
rats
fed
l5
m
g
/
k
g
/
d
a
y
(l08).
T
e
r
a
t
o
g
e
n
i
c
i
t
y
:
W
h
e
n
a
d
m
i
n
i
s
t
e
r
e
d
o
r
a
l
l
y
to
p
r
e
g
n
a
n
t
r
a
t
s
(5
m
g
/
k
g
)
on
d
a
ys
6-l4
of
gestation,
endosulfan
induced
skeletal
terata
in
fetuses
(l07).
M
u
t
a
g
e
n
i
c
i
t
y
:
Not
m
u
t
a
g
e
n
i
c
in
a
d
o
m
i
n
a
n
t
lethal
s
t
u
d
y
w
i
t
h
m
i
c
e
(l03)
i
n
v
i
t
r
o
tests
(l04)
or
in
tests
in
rats
desi
ned
to
determine
effects
on
s
o
m
a
t
i
c
a
n
d
g
e
r
m
i
n
a
l
c
e
l
l
s
(
l
0
5
,
l
O
G
)
.
P
e
r
m
i
s
s
i
b
l
e
E
x
p
o
s
u
r
e
L
i
m
i
t
:
O.l
m
g
/
m
3
f
o
r
s
k
i
n
(43).
I
m
m
e
d
i
a
t
e
l
y
Dangerous
to
Life
or
Health:
Probable
lethal
dose
in
humans
is
5
0
-
5
0
0
m
g
/
k
g
(74).
78
 Existing Environmentai Reguiations: None known.
  
Recommendation: Endosuifan has significant acute and chronic toxicity for man,
'_—
w—_ and it is used extensively in the Great Lakes Basin (>iO6 kg/
annum). Little is known of its environmentai fate. Surveiiiance for
Endosuifan is recommended in fish and water to determine ieveis and
trends.
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